{"content":"<li class=\"n-box-item date-title\" data-end=\"1547873999\" data-start=\"1547787600\" data-txt=\"Monday, December 23, 2019\">Friday, January 18, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3424420\" data-ts=\"1547852086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNBR\" target=\"_blank\">NNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424420-nn-up-1_9-legion-partners-reports-6_53-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NN up 1.9% as Legion Partners reports 6.53% stake</a></h4><ul>   <li>Industrial assembly maker NN (NASDAQ:<a href='https://seekingalpha.com/symbol/NNBR' title='NN, Inc.'>NNBR</a>) is <font color=\"green\">up 1.9%</font> after hours after an <a href=\"https://seekingalpha.com/filing/4307670\" target=\"_blank\">SEC disclosure</a> shows a new stake from Legion Partners.</li>    <li>The firm and affiliates report a 6.53% stake.</li>    <li>Legion also says it and affiliates \"have had and anticipate having further discussions with management and the Board of the Issuer relating to the Issuer\u2019s underperformance, overall business strategy, board composition (which include reconstitution of the Board), corporate governance, management accountability, capital allocation, and the evaluation of strategic alternatives.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424420\" data-linked=\"NN up 1.9% as Legion Partners reports 6.53% stake\" data-tweet=\"$NNBR - NN up 1.9% as Legion Partners reports 6.53% stake https://seekingalpha.com/news/3424420-nn-up-1_9-legion-partners-reports-6_53-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3424420-nn-up-1_9-legion-partners-reports-6_53-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424415\" data-ts=\"1547851442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NG\" target=\"_blank\">NG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424415-skt-ng-goro-and-bzun-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SKT, NG, GORO and BZUN among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/NG' title='NovaGold Resources, Inc'>NG</a> <font color=\"green\">+4.3%</font>. <a href='https://seekingalpha.com/symbol/CXP' title='Columbia Property Trust, Inc.'>CXP</a> <font color=\"green\">+2.4%</font>. <a href='https://seekingalpha.com/symbol/NNBR' title='NN, Inc.'>NNBR</a> <font color=\"green\">+1.9%</font>. <a href='https://seekingalpha.com/symbol/BZUN' title='Baozun'>BZUN</a> <font color=\"green\">+1.4%</font>. <a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a> <font color=\"green\">+1.1%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/DOC' title='Physicians Realty Trust'>DOC</a> <font color=\"red\">-2.8%</font>. <a href='https://seekingalpha.com/symbol/FWONA' title='Liberty Media Corp'>FWONA</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color=\"red\">-1.8%</font>. <a href='https://seekingalpha.com/symbol/GORO' title='Gold Resource Corporation'>GORO</a> <font color=\"red\">-1.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424415\" data-linked=\"SKT, NG, GORO and BZUN among notable after hour movers\" data-tweet=\"$NG $NG $CXP - SKT, NG, GORO and BZUN among notable after hour movers https://seekingalpha.com/news/3424415-skt-ng-goro-and-bzun-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424415-skt-ng-goro-and-bzun-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424414\" data-ts=\"1547851266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424414-wsj-snap-pushed-out-execs-after-probe-relationship\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Snap pushed out execs after probe into relationship</a></h4><ul>   <li>Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) recently ousted two senior execs following a probe that found one had an <a href=\"https://www.wsj.com/articles/two-snap-executives-pushed-out-after-probe-into-inappropriate-relationship-11547850401?mod=breakingnews\" target=\"_blank\">inappropriate relationship</a> with a contractor, <i>The Wall Street Journal</i> reports.</li>    <li>Shares are <font color=\"red\">down 1.5%</font> on heavy after-hours volume.</li>    <li>Late last year the company fired Francis Racioppi, head of global security, after it reportedly found he had an affair with a woman he had hired and then terminated her contract when the relationship ended, according to the report. Racioppi maintains he did nothing wrong and said he retained an attorney.</li>    <li>Meanwhile, the company's head of human resources, Jason Halbert, said he'd leave the company this week. He wasn't directly involved in the situation but had recruited Racioppi, adn WSJ says Snap chief Evan Spiegel asked Halbert to leave.</li>    <li>Those moves predated the most serious recent executive departure, <a href=\"https://seekingalpha.com/news/3423321-snap-minus-4_9-percent-cfo-resigns\" target=\"_blank\">that of CFO Tim Stone</a> after less than an eight-month tenure at the beleaguered company.</li><li>Snap shares <font color=\"green\">rose 7.7%</font> during the regular session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424414\" data-linked=\"WSJ: Snap pushed out execs after probe into relationship\" data-tweet=\"$SNAP - WSJ: Snap pushed out execs after probe into relationship https://seekingalpha.com/news/3424414-wsj-snap-pushed-out-execs-after-probe-relationship?source=tweet\" data-url=\"https://seekingalpha.com/news/3424414-wsj-snap-pushed-out-execs-after-probe-relationship\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424399\" data-ts=\"1547846762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPCO\" target=\"_blank\">TPCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424399-soon-shiong-tribune-publishing-enter-standstill-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soon-Shiong, Tribune Publishing enter standstill deal</a></h4><ul>   <li>Billionaire Patrick Soon-Shiong and affiliates have entered into a <a href=\"https://seekingalpha.com/filing/4307614\" target=\"_blank\">standstill and voting agreement</a> with Tribune Publishing (NASDAQ:<a href='https://seekingalpha.com/symbol/TPCO' title='Tribune Publishing Company'>TPCO</a>) to last until June 30, 2020.</li>    <li>During that period, the \"PSS parties\" won't solicit proxies or look to influence votes, try to influence management or take actions that would require the company to make a related public announcement.</li>    <li>Those parties also agreed to vote shares in favor of board-recommended candidates and to vote along with the board on any change of control transaction.</li>    <li><a href='https://seekingalpha.com/symbol/TPCO' title='Tribune Publishing Company'>TPCO</a> finished the day <font color=\"red\">down 8.1%</font>; it <a href=\"https://seekingalpha.com/news/3424124-tribune-publishing-names-new-leaders-chairman-ceo-dearborn-exits\" target=\"_blank\">named new leadership</a> to replace Justin Dearborn as CEO and chairman late yesterday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424399\" data-linked=\"Soon-Shiong, Tribune Publishing enter standstill deal\" data-tweet=\"$TPCO - Soon-Shiong, Tribune Publishing enter standstill deal https://seekingalpha.com/news/3424399-soon-shiong-tribune-publishing-enter-standstill-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3424399-soon-shiong-tribune-publishing-enter-standstill-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424380\" data-ts=\"1547844855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIEGY\" target=\"_blank\">SIEGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424380-siemens-alstom-rail-merger-set-to-be-rejected-eu-authorities-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Siemens-Alstom rail merger set to be rejected by EU authorities - Reuters</a></h4><ul><li>The European rail champion planned by Siemens (<a href='https://seekingalpha.com/symbol/SIEGY' title='Siemens AG ADR'>OTCPK:SIEGY</a> <font color=\"green\">+2.2%</font>) and Alstom (<a href='https://seekingalpha.com/symbol/ALSMY' title='Alstom ADR'>OTCPK:ALSMY</a> <font color=\"red\">-3.3%</font>) has <a href=\"https://www.reuters.com/article/us-alstom-m-a-siemens-eu/eu-to-derail-siemens-alstoms-european-champion-plan-sources-idUSKCN1PC2AY\" target=\"_blank\">failed to win over</a> European Union antitrust regulators despite German and French backing, Reuters reports.</li><li>The EU veto, to be announced early next month, could push Siemens to float its own in-house rail technology division, called Siemens Mobility, according to the report.</li><li>Germany and France support the deal, saying it would help secure the competitiveness of the European rail industry, but the view of European Competition Commissioner Vestager is that Europe cannot build industrial champions by undermining competition.</li><li>The rail merger deal would have created the world\u2019s second largest rail company, with combined revenues of ~\u20ac15B ($17.05B).</li><li><a href=\"https://seekingalpha.com/news/3423929-siemens-alstom-said-rule-merger-concessions\" target=\"_blank\">Earlier</a>: Siemens, Alstom said to rule out more merger concessions (Jan. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424380\" data-linked=\"Siemens-Alstom rail merger set to be rejected by EU authorities - Reuters\" data-tweet=\"$SIEGY $SIEGY $ALSMY - Siemens-Alstom rail merger set to be rejected by EU authorities - Reuters https://seekingalpha.com/news/3424380-siemens-alstom-rail-merger-set-to-be-rejected-eu-authorities-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3424380-siemens-alstom-rail-merger-set-to-be-rejected-eu-authorities-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424377\" data-ts=\"1547843402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USCR\" target=\"_blank\">USCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424377-trump-reportedly-wants-to-revive-infrastructure-push-materials-stocks-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump reportedly wants to revive infrastructure push; materials stocks gain</a></h4><ul><li>Construction names U.S. Concrete (<a href='https://seekingalpha.com/symbol/USCR' title='US Concrete Inc.'>USCR</a> <font color='green'>+6.1%</font>), Vulcan Materials (<a href='https://seekingalpha.com/symbol/VMC' title='Vulcan Materials Company'>VMC</a> <font color='green'>+2.3%</font>), Eagle Materials (<a href='https://seekingalpha.com/symbol/EXP' title='Eagle Materials Inc.'>EXP</a> <font color='green'>+4.1%</font>) and Summit Materials (<a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials'>SUM</a> <font color='green'>+5.2%</font>) all enjoy strong gains after reports say Pres. Trump is trying to <a href=\"https://www.cnbc.com/2019/01/18/a-new-trump-infrastructure-plan-could-cost-1-trillion.html\" target=\"_blank\">revive support for his stalled $1T infrastructure plan</a>.</li><li>The White House held a high-level meeting Tuesday led by National Economic Council Director Larry Kudlow to chart potential paths forward, CNBC reports.</li><li>Among issued said to have been debated were reform in the permitting process, support for energy industry projects  in the Permian Basin and potential revenue from a controversial hike of  the federal gas tax.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424377\" data-linked=\"Trump reportedly wants to revive infrastructure push; materials stocks gain\" data-tweet=\"$USCR $USCR $VMC - Trump reportedly wants to revive infrastructure push; materials stocks gain https://seekingalpha.com/news/3424377-trump-reportedly-wants-to-revive-infrastructure-push-materials-stocks-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3424377-trump-reportedly-wants-to-revive-infrastructure-push-materials-stocks-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424370\" data-ts=\"1547841615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IZEA\" target=\"_blank\">IZEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424370-microcaps-dominate-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate tech movers</a></h4><ul><li><strong>Gainers: </strong>IZEA Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a>) <font color=\"green\">+14%</font>. Aehr Test Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a>) <font color=\"green\">+12%</font>. Remark Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a>) <font color=\"green\">+11%</font>. Turtle Beach Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) <font color=\"green\">+11%</font>. iCAD (NASDAQ:<a href='https://seekingalpha.com/symbol/ICAD' title='iCAD, Inc.'>ICAD</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers: </strong>Casa Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a>) <font color=\"red\">-21%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a>) <font color=\"red\">-10%</font>. Telecom Italia S.p.A. (NYSE:<a href='https://seekingalpha.com/symbol/TI.A' title='Telecom Italia S.P.A.'>TI.A</a>) <font color=\"red\">-8%</font>. Intelsat S.A. (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) <font color=\"red\">-6%</font>. FTE Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424370\" data-linked=\"Microcaps dominate tech movers\" data-tweet=\"$IZEA $IZEA $AEHR - Microcaps dominate tech movers https://seekingalpha.com/news/3424370-microcaps-dominate-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424370-microcaps-dominate-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424371\" data-ts=\"1547841584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLT\" target=\"_blank\">FLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424371-fleetcorplus-2-btig-starts-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FleetCor +2% as BTIG starts with Buy rating</a></h4><ul><li>FleetCor Technologies (<a href='https://seekingalpha.com/symbol/FLT' title='FleetCor Technologies, Inc.'>FLT</a> <font color=\"green\">+2.4%</font>) is higher after BTIG analyst Mark Palmer initiates coverage with a <a href=\"https://thefly.com/thestreet/realmoney/index.php/FLTid2850563/FLT-FleetCor-initiated-with-a-Buy-at-BTIG\" target=\"_blank\">Buy rating</a> and $253 price target, saying the company's recurring revenue, high operating leverage and EBITDA margins north of 50% merits investors' attention.</li><li>Palmer also sees the shares as attractively valued following the pullback that began in late September.</li><li>Both FLT and Wex Inc. (<a href='https://seekingalpha.com/symbol/WEX' title='WEX Inc.'>WEX</a> <font color=\"green\">+2.4%</font>) are well positioned to benefit from the \"ongoing cash-to-card displacement trend,\" Palmer writes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424371\" data-linked=\"FleetCor +2% as BTIG starts with Buy rating\" data-tweet=\"$FLT $FLT $WEX - FleetCor +2% as BTIG starts with Buy rating https://seekingalpha.com/news/3424371-fleetcorplus-2-btig-starts-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3424371-fleetcorplus-2-btig-starts-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424351\" data-ts=\"1547837912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IO\" target=\"_blank\">IO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424351-ion-geophysical-and-earthstone-energy-among-energy-materials-gainers-saexploration-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ION Geophysical and Earthstone Energy among Energy/Materials gainers; SAExploration among losers</a></h4><ul><li><b>Gainers: </b>ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color=\"green\">+11%</font>. Earthstone Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a>) <font color=\"green\">+9%</font>. Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>) <font color=\"green\">+8%</font>. Schlumberger (NYSE:<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a>) <font color=\"green\">+8%</font>. Sanchez Midstream Partners (NYSEMKT:<a href='https://seekingalpha.com/symbol/SNMP' title='Sanchez Midstream Partners LP'>SNMP</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424351\" data-linked=\"ION Geophysical and Earthstone Energy among Energy/Materials gainers; SAExploration among losers\" data-tweet=\"$IO $IO $ESTE - ION Geophysical and Earthstone Energy among Energy/Materials gainers; SAExploration among losers https://seekingalpha.com/news/3424351-ion-geophysical-and-earthstone-energy-among-energy-materials-gainers-saexploration-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3424351-ion-geophysical-and-earthstone-energy-among-energy-materials-gainers-saexploration-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424350\" data-ts=\"1547837773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424350-fda-rejection-of-immunomedics-tnbc-candidate-not-related-to-clinical-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejection of Immunomedics&#39; TNBC candidate not related to clinical data</a></h4><ul><li>Immunomedics (<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color=\"red\">-26.4%</font>) is currently trading <font color=\"green\">~16%</font> above the intraday low of $11.57 as bargain hunters move in after shares plummeted in reaction to the <a href=\"https://seekingalpha.com/news/3424153-immunomedics-receives-crl-sacituzumab-govitecan\" target=\"_blank\">FDA's rejection</a> of its marketing application seeking approval for antibody-drug conjugate &#40;ADC&#41; sacituzumab govitecan for triple-negative breast cancer &#40;TNBC&#41;.</li><li>The company says the CRL cited issues with Chemistry, Manufacturing and Controls &#40;CMC&#41;, adding that no additional clinical or preclinical data are needed. It plans to meet with the agency as soon as possible to clarify what needs to be done to support a refiling.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424350\" data-linked=\"FDA rejection of Immunomedics&#39; TNBC candidate not related to clinical data\" data-tweet=\"$IMMU - FDA rejection of Immunomedics&#39; TNBC candidate not related to clinical data https://seekingalpha.com/news/3424350-fda-rejection-of-immunomedics-tnbc-candidate-not-related-to-clinical-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3424350-fda-rejection-of-immunomedics-tnbc-candidate-not-related-to-clinical-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424349\" data-ts=\"1547837297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424349-fear-index-starts-year-in-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">`Fear index&#39; starts the year in decline</a></h4><ul><li>The so-called fear index <a href=\"https://www.marketwatch.com/story/wall-streets-fear-index-is-on-track-for-its-biggest-one-month-plunge-in-nearly-3-years-2019-01-18\" target=\"_blank\">is on pace</a> for its biggest one-month decline in three years, according to FactSet data.</li><li>The Cboe Volatility Index, or VIX, uses S&amp;P 500 options to assess volatility over the next 30 days and tends to trade inversely to stocks.</li><li>So far in January, stocks have been rising more than falling, in stark contrast to the wide swings in the market during November and December.</li><li>At 11:10 AM ET, the VIX was at 17.40, a decline of about 31.6% so far in January. If it closes Friday about that level, it would be the largest decline since March 2016, when it fell 32.1%.</li><li>At about 1:30 PM ET, the VIX is 17.66.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3419837-scorecard-markets-2018\" target=\"_blank\">Scorecard for the markets in 2018</a> (Jan. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424349\" data-linked=\"`Fear index&#39; starts the year in decline\" data-tweet=\"`Fear index&#39; starts the year in decline https://seekingalpha.com/news/3424349-fear-index-starts-year-in-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3424349-fear-index-starts-year-in-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424348\" data-ts=\"1547836837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424348-ft-spotify-plans-in-car-voice-controlled-music-player\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FT: Spotify plans in-car voice-controlled music player</a></h4><ul>   <li>Spotify (<a href=\"http://seekingalpha.com/symbol/SPOT\" target=\"_blank\">SPOT</a> <font color=\"green\">+0.9%</font>) is planning its first push into hardware this year, via a voice-controlled <a href=\"https://www.ft.com/content/bcc9b71a-1b33-11e9-b93e-f4351a53f1c3\" target=\"_blank\">in-car music player</a>, the <i>Financial Times</i> reports.</li>    <li>That's a move that could break it away somewhat from dependence on devices made by Apple (<a href=\"http://seekingalpha.com/symbol/AAPL\" target=\"_blank\">AAPL</a> <font color=\"green\">+0.9%</font>), Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color=\"green\">+1.3%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color=\"green\">+1.3%</font>) and Amazon.com (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color=\"green\">+0.8%</font>), even as those three giants push their own music services.</li>    <li>Spotify's device would be built by Flex (<a href=\"http://seekingalpha.com/symbol/FLEX\" target=\"_blank\">FLEX</a> <font color=\"green\">+2.3%</font>) and cost about $100 -- cheaper than most brand-name car stereos, according to the report.</li>    <li>It would sync to the car's system via Bluetooth, as well as feature preset buttons corresponding to playlists along with the voice control (based on its in-house Spotify Voice, which began rolling out last year).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424348\" data-linked=\"FT: Spotify plans in-car voice-controlled music player\" data-tweet=\"$GOOG $GOOG $GOOGL - FT: Spotify plans in-car voice-controlled music player https://seekingalpha.com/news/3424348-ft-spotify-plans-in-car-voice-controlled-music-player?source=tweet\" data-url=\"https://seekingalpha.com/news/3424348-ft-spotify-plans-in-car-voice-controlled-music-player\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424341\" data-ts=\"1547834677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMK\" target=\"_blank\">WMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424341-weis-markets-begins-price-slashing-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weis Markets begins price-slashing program</a></h4><ul><li>Weis Markets (<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='green'>+0.5%</font>) <a href=\"https://www.pennlive.com/food/2019/01/weis-markets-slashes-prices-on-more-than-7000-items.html\" target=\"_blank\">plans</a> to lower prices on more than 7K items today.</li><li>The company says it's making a multi-million-dollar investment to provide the lowest price in the market on the large number of everyday products.</li><li>That's not the sort of announcement that will slide right past Spruce Point Capital Management. \"More margin compression,\" warns the firm with a <a href=\"https://seekingalpha.com/article/4204215-price-checks-big-data-analysis-forensic-accounting-review-suggest-financial-strain-weis\" target=\"_blank\">bearish tilt</a> on WMK.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424341\" data-linked=\"Weis Markets begins price-slashing program\" data-tweet=\"$WMK - Weis Markets begins price-slashing program https://seekingalpha.com/news/3424341-weis-markets-begins-price-slashing-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3424341-weis-markets-begins-price-slashing-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424339\" data-ts=\"1547834243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OZK\" target=\"_blank\">OZK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424339-bank-ozk-leads-financial-gainers-china-commercial-credit-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank OZK leads financial gainers; China Commercial Credit among losers</a></h4><ul><li><b>Gainers: </b>Bank OZK (NASDAQ:<a href='https://seekingalpha.com/symbol/OZK' title='Bank OZK'>OZK</a>) <font color=\"green\">+15%</font>. Camping World Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a>) <font color=\"green\">+11%</font>. Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"green\">+10%</font>. Fanhua (NASDAQ:<a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a>) <font color=\"green\">+9%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"red\">-15%</font>. China Commercial Credit (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Commercial Credit, Inc.'>GLG</a>) <font color=\"red\">-14%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424339\" data-linked=\"Bank OZK leads financial gainers; China Commercial Credit among losers\" data-tweet=\"$OZK $OZK $CWH - Bank OZK leads financial gainers; China Commercial Credit among losers https://seekingalpha.com/news/3424339-bank-ozk-leads-financial-gainers-china-commercial-credit-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424339-bank-ozk-leads-financial-gainers-china-commercial-credit-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424337\" data-ts=\"1547834101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424337-h-c-wainwright-defends-tyme-tech-shares-down-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H.C. Wainwright defends Tyme Tech; shares down 38%</a></h4><ul><li>Uber-bull H.C. Wainwright (BUY/$10) says today's drop in Tyme Technologies (<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a> <font color=\"red\">-37.5%</font>) is a \"buying opportunity.\" Shares dropped as much as <font color=\"red\">46%</font> after the company <a href=\"https://seekingalpha.com/news/3424215-tymes-smminus-88-improved-survival-mid-stage-pancreatic-cancer-study\" target=\"_blank\">announced</a> mid-stage SM-88 survival data in advanced pancreatic cancer that failed to withstand scrutiny.</li><li>Bargain hunters have moved in, though. Shares are currently exchanging hands at <font color=\"green\">~17%</font> above the intraday low of $2.00. Volume is six times normal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424337\" data-linked=\"H.C. Wainwright defends Tyme Tech; shares down 38%\" data-tweet=\"$TYME - H.C. Wainwright defends Tyme Tech; shares down 38% https://seekingalpha.com/news/3424337-h-c-wainwright-defends-tyme-tech-shares-down-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3424337-h-c-wainwright-defends-tyme-tech-shares-down-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424336\" data-ts=\"1547833378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSKE\" target=\"_blank\">DSKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424336-daseke-rides-dane-capital-call-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daseke rides Dane Capital call higher</a></h4><ul> <li>Daseke (NASDAQ:<a href='https://seekingalpha.com/symbol/DSKE' title='Daseke, Inc.'>DSKE</a>) runs up a <font color=\"green\">9.51% gain</font> to trade at its highest level of 2019.</li> <li>While there's pretty vibrant rally going in the trucking sector as a whole off solid earnings, Daseke is easily leading the pack after being identified by <a href=\"https://seekingalpha.com/article/4234210-spacs-attack-q4-insiders-stepping\" target=\"_blank\">Dane Capital Management</a> early today as being undervalued.</li> <li>\"Daseke now trades at an extremely undemanding 4.4x 2019 EV/EBITDA, based on our estimate of $200mn of EBITDA,\" notes the firm.</li> <li>The long call on Daseke is part of Dane's thesis that SPACs in general were hit hard by tax loss selling, fund redemptions, concerns about interest rates and a recession, and in cases, a lack of a strong institutional appreciation for the names.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424336\" data-linked=\"Daseke rides Dane Capital call higher\" data-tweet=\"$DSKE - Daseke rides Dane Capital call higher https://seekingalpha.com/news/3424336-daseke-rides-dane-capital-call-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3424336-daseke-rides-dane-capital-call-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424333\" data-ts=\"1547833291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BASFY\" target=\"_blank\">BASFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424333-basf-wins-eu-conditional-approval-for-solvays-nylon-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BASF wins EU conditional approval for Solvay&#39;s nylon business</a></h4><ul><li>The European Commission gives <a href=\"https://www.reuters.com/article/us-solvay-m-a-basf/basf-wins-eus-conditional-approval-for-purchase-of-solvays-nylon-business-idUSKCN1PC10J\" target=\"_blank\">conditional approval</a> to BASF's (<a href='https://seekingalpha.com/symbol/BASFY' title='BASF SE ADR'>OTCQX:BASFY</a> <font color='green'>+3.4%</font>) acquisition of the nylon business of Belgian rival Solvay (<a href='https://seekingalpha.com/symbol/SVYSF' title='Solvay S.A.'>OTCQX:SVYSF</a>).</li><li>The EU antitrust regulator says Solvay must divest its facilities in France, Poland and Spain to a single buyer to guarantee competition in Europe, and requires the creation of a production joint venture in France for the production of adipic acid.</li><li>BASF agreed in 2017 to buy Solvay's nylon business for \u20ac1.6B ($1.8B) to boost its engineering plastics portfolio and improve access to growth markets in Asia and South America.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424333\" data-linked=\"BASF wins EU conditional approval for Solvay&#39;s nylon business\" data-tweet=\"$BASFY $BASFY $SVYSF - BASF wins EU conditional approval for Solvay&#39;s nylon business https://seekingalpha.com/news/3424333-basf-wins-eu-conditional-approval-for-solvays-nylon-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3424333-basf-wins-eu-conditional-approval-for-solvays-nylon-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424332\" data-ts=\"1547833090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOFO\" target=\"_blank\">SOFO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424332-midday-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday movers and shakers</a></h4><ul><li><strong>Gainers:</strong> Sonic Foundry (<a href='https://seekingalpha.com/symbol/SOFO' title='Sonic Foundry, Inc.'>OTC:SOFO</a>) <font color=\"green\">+19%</font>. Rafael Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/RFL' title='Rafael Holdings, Inc.'>RFL</a>) <font color=\"green\">+15%</font>. Turtle Beach (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) <font color=\"green\">+14%</font>. Hi-Crush Partners LP (NYSE:<a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a>) <font color=\"green\">+14%</font>. Bank OZK (NASDAQ:<a href='https://seekingalpha.com/symbol/OZK' title='Bank OZK'>OZK</a>) <font color=\"green\">+14%</font>. Superior Drilling Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a>) <font color=\"green\">+13%</font>. Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) <font color=\"green\">+13%</font>. PLx Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/PLXP' title='PLx Pharma'>PLXP</a>) <font color=\"green\">+13%</font>. V.F. Corporation (NYSE:<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a>) <font color=\"green\">+12%</font>. Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"green\">+12%</font>.</li><li><strong>Losers:</strong> Organogenesis Holdings (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc'>ORGO</a>) <font color=\"red\">-42%</font>. Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>) <font color=\"red\">-38%</font>. Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-37%</font>. Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) <font color=\"red\">-28%</font>. Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"red\">-24%</font>. Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"red\">-22%</font>. Casa Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a>) <font color=\"red\">-22%</font>. Unity Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/UBX' title='Unity Biotechnology'>UBX</a>) <font color=\"red\">-15%</font>. LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"red\">-15%</font>. China Commercial Credit (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Commercial Credit, Inc.'>GLG</a>) <font color=\"red\">-14%</font>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3424332\" data-linked=\"Midday movers and shakers\" data-tweet=\"$SOFO $SOFO $RFL - Midday movers and shakers https://seekingalpha.com/news/3424332-midday-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424332-midday-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424330\" data-ts=\"1547832506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424330-schlumbergerplus-8-after-upbeat-guidance-lower-2019-capex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schlumberger +8% after upbeat guidance, lower 2019 capex</a></h4><ul><li>Schlumberger (<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='green'>+7.8%</font>) shares are on track for their biggest one-day gain since 2011 following the company's <a href=\"https://seekingalpha.com/news/3424197-schlumberger-plus-3-percent-line-q4-earnings-foresees-international-growth\" target=\"_blank\">upbeat guidance for 2019</a>, seeing clear signs that E&amp;P investments are beginning to normalize.</li><li>SLB says it <a href=\"https://www.reuters.com/article/us-schlumberger-results/schlumberger-shares-rise-on-lower-2019-capex-international-outlook-idUSKCN1PC1BS\" target=\"_blank\">will spend less in 2019</a>, expecting capital spending of $1.5B-$1.7B vs. $2.2B in 2018, driven by lower spending in North America, CEO Paal Kibsgaard said during today's earnings conference call.</li><li>\"Future investments will likely be much closer to a level that can be covered by free cash flow,\" Kibsgaard said about SLB's U.S. operator customers, adding that the company had built \"significant flexibility\" into its 2019 operating plan.</li><li>Brian Youngberg, a senior energy analyst for Edward Jones, says the downward capex guidance helps solidify the safety of SLB's dividend.</li><li>Cowen's Marc Bianchi reiterates an Outperform rating and $48 price target on the stock, noting <a href=\"https://www.barrons.com/articles/schlumberger-earnings-are-fueling-a-rebound-in-the-stock-after-a-2018-slide-51547830877?mod=hp_INTERESTS_commodities&amp;refsec=commodities\" target=\"_blank\">positives from SLB's Q4 results</a> include cash flow generation, reduced debt and a 44% increase in orders for its OneSubsea unit.</li><li>Stephens analyst Tommy Moll likes SLB\u2019s lower capex outlook but warns \"an increased capital discipline focus in North America (in a lower commodity environment) implies a lower-than-expected range (and a reduction in activity levels).\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3424330\" data-linked=\"Schlumberger +8% after upbeat guidance, lower 2019 capex\" data-tweet=\"$SLB - Schlumberger +8% after upbeat guidance, lower 2019 capex https://seekingalpha.com/news/3424330-schlumbergerplus-8-after-upbeat-guidance-lower-2019-capex?source=tweet\" data-url=\"https://seekingalpha.com/news/3424330-schlumbergerplus-8-after-upbeat-guidance-lower-2019-capex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424320\" data-ts=\"1547830826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VFC\" target=\"_blank\">VFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424320-v-f-corporation-leads-consumer-gainers-tesla-and-nautilus-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">V.F. Corporation leads consumer gainers; Tesla and Nautilus in losers</a></h4><ul><li><b>Gainers: </b>V.F. Corporation (NYSE:<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a>) <font color=\"green\">+11%</font>. Sanderson Farms (NASDAQ:<a href='https://seekingalpha.com/symbol/SAFM' title='Sanderson Farms, Inc.'>SAFM</a>) <font color=\"green\">+7%</font>. REV Group (NYSE:<a href='https://seekingalpha.com/symbol/REVG' title='REV Group'>REVG</a>) <font color=\"green\">+7%</font>. Pilgrim's Pride (NYSE:<a href='https://seekingalpha.com/symbol/PPC' title='Pilgrim&#39;s Pride Corporation'>PPC</a>) <font color=\"green\">+7%</font>. Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>) <font color=\"red\">-38%</font>. Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424320\" data-linked=\"V.F. Corporation leads consumer gainers; Tesla and Nautilus in losers\" data-tweet=\"$VFC $VFC $SAFM - V.F. Corporation leads consumer gainers; Tesla and Nautilus in losers https://seekingalpha.com/news/3424320-v-f-corporation-leads-consumer-gainers-tesla-and-nautilus-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424320-v-f-corporation-leads-consumer-gainers-tesla-and-nautilus-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424315\" data-ts=\"1547829704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VFC\" target=\"_blank\">VFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424315-government-shutdown-delays-v-f-corp-spinoff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Government shutdown delays V.F. Corp spinoff</a></h4><ul> <li>V.F. Corp (<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a> <font color=\"green\">+11.7%</font>) CFO Scott Roe says the government shutdown could push back the company's spinoff of Kontoor Brands into a new company.</li> <li>The disclosure was made during the company's <a href=\"https://seekingalpha.com/article/4234258-v-f-corporation-2019-q3-results-earnings-call-slides\" target=\"_blank\">earnings conference call</a>.</li> <li>Shares of VFC have rallied to their highest level of the year following a well-received earnings report.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424186-v-f-corp-plus-10-percent-strong-earnings\" target=\"_blank\">V.F. Corp +10% after strong earnings</a> (Jan. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424315\" data-linked=\"Government shutdown delays V.F. Corp spinoff\" data-tweet=\"$VFC $KTB - Government shutdown delays V.F. Corp spinoff https://seekingalpha.com/news/3424315-government-shutdown-delays-v-f-corp-spinoff?source=tweet\" data-url=\"https://seekingalpha.com/news/3424315-government-shutdown-delays-v-f-corp-spinoff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424314\" data-ts=\"1547829643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424314-telecom-italiaminus-6_3-after-slide-in-ebitda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Italia -6.3% after slide in EBITDA</a></h4><ul>   <li>Telecom Italia (NYSE:<a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.P.A.'>TI</a>) is <font color=\"red\">6.3% lower</font> on the NYSE today after yesterday's <a href=\"https://seekingalpha.com/news/3423992-telecom-italia-expects-organic-drop-ebitda-2018\" target=\"_blank\">preliminary release</a> showed an expected organic drop to 2018 domestic EBITDA.</li>    <li>The news was out during NYSE trading hours yesterday, but today's move tracks a <font color=\"red\">7.2% decline</font> for the company's stock today in Milan.</li>    <li>That release comes from TI's new management, led by Elliott Management -- which could again face a stand-off with top shareholder Vivendi (<a href='https://seekingalpha.com/symbol/VIVHY' title='Vivendi SA ADR'>OTCPK:VIVHY</a>) for control at the next shareholder meeting. Elliott wrestled control of the company from Vivendi last spring.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424314\" data-linked=\"Telecom Italia -6.3% after slide in EBITDA\" data-tweet=\"$TI $TI $VIVHY - Telecom Italia -6.3% after slide in EBITDA https://seekingalpha.com/news/3424314-telecom-italiaminus-6_3-after-slide-in-ebitda?source=tweet\" data-url=\"https://seekingalpha.com/news/3424314-telecom-italiaminus-6_3-after-slide-in-ebitda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424309\" data-ts=\"1547828679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424309-semis-outperform-on-trade-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis outperform on trade optimism</a></h4><ul><li>The Philadelphia Semiconductor Index<font color=\"green\"> gains 2.7%</font> compared to the <font color=\"green\">1.4%</font> gain for the tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) on US-China trade optimism and a BofAML upgrade for Silicon Motion.</li><li>On the move: (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='green'>+4.7%</font>), (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='green'>+3.7%</font>), (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='green'>+4.4%</font>), (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+6%</font>), (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='green'>+3.3%</font>), (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+1.6%</font>),(<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+2.9%</font>), (<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a> <font color='green'>+2.2%</font>).</li><li>Upcoming earnings: Lam and Texas instruments report on January 23.</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424309\" data-linked=\"Semis outperform on trade optimism\" data-tweet=\"$LRCX $XLK $LRCX - Semis outperform on trade optimism https://seekingalpha.com/news/3424309-semis-outperform-on-trade-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3424309-semis-outperform-on-trade-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424308\" data-ts=\"1547828468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIF\" target=\"_blank\">TIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424308-tiffanys-sales-in-mainland-china-accelerate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tiffany&#39;s sales in Mainland China accelerate</a></h4><ul> <li>Tiffany (<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a> <font color='green'>+4.1%</font>) trades higher after the retailer's <a href=\"https://www.bloomberg.com/news/articles/2019-01-18/mainland-china-provides-silver-lining-to-tiffany-holiday-results\" target=\"_blank\">update </a>on China took some of the sting off profit guidance that arrived with a midpoint below consensus.</li><li>Tiffany churned up double-digit sales growth in Mainland China during the final two months of the year in a noteworthy acceleration from the prior pace of growth.</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3424169-holiday-sales-disappoint-tiffany\" target=\"_blank\">Holiday sales disappoint at Tiffany</a> (Jan. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424308\" data-linked=\"Tiffany&#39;s sales in Mainland China accelerate\" data-tweet=\"$TIF - Tiffany&#39;s sales in Mainland China accelerate https://seekingalpha.com/news/3424308-tiffanys-sales-in-mainland-china-accelerate?source=tweet\" data-url=\"https://seekingalpha.com/news/3424308-tiffanys-sales-in-mainland-china-accelerate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424307\" data-ts=\"1547828317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FANH\" target=\"_blank\">FANH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424307-fanhuaplus-8_6-after-defending-against-short-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fanhua +8.6% after defending against short report</a></h4><ul><li>Fanhua (NASDAQ:<a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a>) <font color=\"green\">rebounds 8.6%</font> after defending against a report that it said attempted to profit from the company's stock decline through a \"short-selling attack.\"</li><li>On Thursday, Fanhua dropped 12% after the report was published.</li><li>The company <a href=\"https://seekingalpha.com/pr/17384826-fanhua-issues-solemn-statement-unusual-trading-activities\" target=\"_blank\">is reviewing</a> the report and will make an announcement clarifying and refuting allegations raised in the report before the market opens on Jan. 22.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424307\" data-linked=\"Fanhua +8.6% after defending against short report\" data-tweet=\"$FANH - Fanhua +8.6% after defending against short report https://seekingalpha.com/news/3424307-fanhuaplus-8_6-after-defending-against-short-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3424307-fanhuaplus-8_6-after-defending-against-short-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424306\" data-ts=\"1547828086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424306-crude-oil-rallies-china-said-to-offer-plan-to-eliminate-trade-imbalance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil rallies as China said to offer plan to eliminate trade imbalance</a></h4><ul><li><a href=\"https://www.cnbc.com/2019/01/18/oil-markets-opec-output-cuts-us-china-trade-tensions-in-focus.html\" target=\"_blank\">Crude oil surges to six-week highs</a> after China reportedly has offered to ramp up its purchases of U.S. imports over six years to $1T/year, with the goal of eliminating its trade surplus with the U.S.; WTI <font color=\"green\">+3.4%</font> to $53.87/bbl, Brent <font color=\"green\">+2.8%</font> to $62.92/bbl.</li><li>Both benchmarks are ~4% higher this week, on pace  for a third consecutive week of gains following a three-month collapse  in oil prices.</li><li>Crude futures already were higher <a href=\"https://seekingalpha.com/news/3423754-opec-oil-production-falls-december\" target=\"_blank\">OPEC production fell sharply last month</a>, easing some concerns about prolonged oversupply.</li><li>\u201cThe combination of production cuts by OPEC+ (especially the Saudis) and  tightening sanctions on Iranian oil exports have brought the market  close to balance,\u201d Jefferies analysts say.</li><li>Oil companies trade broadly higher: <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> +0.8%, <a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color=\"green\">+2.1%</font>, <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color=\"green\">+1.4%</font>, <a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color=\"green\">+1.8%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color=\"green\">+1.4%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"green\">+2%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"green\">+1.3%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"green\">+1.8%</font>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color=\"green\">+1.7%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color=\"green\">+3.5%</font>, <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color=\"green\">+3.3%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color=\"green\">+7.2%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color=\"green\">+2.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424306\" data-linked=\"Crude oil rallies as China said to offer plan to eliminate trade imbalance\" data-tweet=\"$XOM $XOM $CVX - Crude oil rallies as China said to offer plan to eliminate trade imbalance https://seekingalpha.com/news/3424306-crude-oil-rallies-china-said-to-offer-plan-to-eliminate-trade-imbalance?source=tweet\" data-url=\"https://seekingalpha.com/news/3424306-crude-oil-rallies-china-said-to-offer-plan-to-eliminate-trade-imbalance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>139&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424305\" data-ts=\"1547827974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWH\" target=\"_blank\">SPWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424305-sportsmans-warehouseplus-4-after-stifel-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sportsman&#39;s Warehouse +4% after Stifel upgrade</a></h4><ul> <li>Sportsman's Warehouse Holdings (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='green'>+4.3%</font>) rallies after Piper Jaffray upgrades the sporting goods retailer to Overweight from Neutral.</li> <li>The Piper analyst team sets a price target of $8 on SPWH, pointing to the low valuation shares currently trade at.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3424305\" data-linked=\"Sportsman&#39;s Warehouse +4% after Stifel upgrade\" data-tweet=\"$SPWH - Sportsman&#39;s Warehouse +4% after Stifel upgrade https://seekingalpha.com/news/3424305-sportsmans-warehouseplus-4-after-stifel-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3424305-sportsmans-warehouseplus-4-after-stifel-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424304\" data-ts=\"1547827873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNT\" target=\"_blank\">FTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424304-fortinetminus-3-on-otr-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortinet -3% on OTR downgrade</a></h4><ul><li>OTR Global downgrades Fortinet (NASDAQ:<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>) from Positive to Mixed citing slightly weaker Q4 business trends.</li><li>But OTR says the Q1 pipeline and 2019 forecasts are still solid.</li><li>Source: Bloomberg First Word.</li><li>FTNT is <font color=\"red\">down 3.2%</font> to $70.36.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424304\" data-linked=\"Fortinet -3% on OTR downgrade\" data-tweet=\"$FTNT - Fortinet -3% on OTR downgrade https://seekingalpha.com/news/3424304-fortinetminus-3-on-otr-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3424304-fortinetminus-3-on-otr-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424303\" data-ts=\"1547827756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424303-china-offers-path-to-cut-u-s-trade-deficit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China offers path to cut U.S. trade deficit</a></h4><ul><li>U.S. stocks' advance gathers steam after a report that <a href=\"https://www.bloomberg.com/news/articles/2019-01-18/china-offers-path-to-eliminate-us-trade-imbalance-sources?srnd=premium\" target=\"_blank\">China offered</a> to boost imports from the U.S. over a six-year period that would eliminate its trade surplus with the U.S.</li><li>S&amp;P and Nasdaq move<font color=\"green\"> up 1.1%</font>; Dow gains over 230 points, <font color=\"green\">up 1.0%</font>.</li><li>Dollar index<font color=\"green\"> +0.2% </font>to 96.30.</li><li>SPDR S&amp;P China ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/GXC' title='SPDR S&P China ETF'>GXC</a>)<font color=\"green\"> gains 1.5%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/YINN' title='Direxion Daily FTSE China Bull 3x Shares ETF'>YINN</a>, <a href='https://seekingalpha.com/symbol/YANG' title='Direxion Daily FTSE China Bear 3x Shares ETF'>YANG</a>, <a href='https://seekingalpha.com/symbol/GXC' title='SPDR S&P China ETF'>GXC</a>, <a href='https://seekingalpha.com/symbol/FXP' title='ProShares UltraShort FTSE China 25 ETF'>FXP</a>, <a href='https://seekingalpha.com/symbol/PGJ' title='Invesco Golden Dragon China Portfolio ETF'>PGJ</a>, <a href='https://seekingalpha.com/symbol/CN' title='Deutsche X-trackers Harvest MSCI All China Equity ETF'>CN</a>, <a href='https://seekingalpha.com/symbol/TDF' title='Templeton Dragon Fund'>TDF</a>, <a href='https://seekingalpha.com/symbol/CHN' title='China Fund'>CHN</a>, <a href='https://seekingalpha.com/symbol/DSUM' title='Invesco Chinese Yuan Dim Sum Bond Portfolio ETF'>DSUM</a>, <a href='https://seekingalpha.com/symbol/CXSE' title='WisdomTree China ex-State-Owned Enterprises ETF'>CXSE</a>, <a href='https://seekingalpha.com/symbol/XPP' title='ProShares Ultra FTSE China 25 ETF'>XPP</a>, <a href='https://seekingalpha.com/symbol/FCA' title='First Trust China AlphaDEX ETF'>FCA</a>, <a href='https://seekingalpha.com/symbol/YAO' title='Invesco China All-Cap ETF'>YAO</a>, <a href='https://seekingalpha.com/symbol/YXI' title='ProShares Short FTSE China 50 ETF'>YXI</a>, <a href='https://seekingalpha.com/symbol/CBON' title='VanEck Vectors ChinaAMC China Bond ETF'>CBON</a>, <a href='https://seekingalpha.com/symbol/KCNY' title='KraneShares E Fund China Commercial Paper ETF'>KCNY</a>, <a href='https://seekingalpha.com/symbol/KGRN' title='KraneShares MSCI China Environment ETF'>KGRN</a>, <a href='https://seekingalpha.com/symbol/FLCH' title='Franklin FTSE China ETF'>FLCH</a>, <a href='https://seekingalpha.com/symbol/WCHN' title='WisdomTree ICBCCS S&P China 500 ETF'>WCHN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424303\" data-linked=\"China offers path to cut U.S. trade deficit\" data-tweet=\"$GXC $YINN $YANG - China offers path to cut U.S. trade deficit https://seekingalpha.com/news/3424303-china-offers-path-to-cut-u-s-trade-deficit?source=tweet\" data-url=\"https://seekingalpha.com/news/3424303-china-offers-path-to-cut-u-s-trade-deficit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>114&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424302\" data-ts=\"1547827576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424302-kura-oncology-up-3-on-encouraging-tipifarnib-data-in-pancreatic-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura Oncology up 3% on encouraging tipifarnib data in pancreatic cancer</a></h4><ul><li>Thinly traded Kura Oncology (<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color=\"green\">+3.4%</font>) is up on light volume following its <a href=\"https://seekingalpha.com/pr/17385143-kura-oncology-reports-clinical-activity-tipifarnib-subsets-pancreatic-cancer-associated-high\" target=\"_blank\">announcement </a>that lead candidate tipifarnib may be effective in treating certain pancreatic cancer patients based on a retrospective analysis of a previously conducted Phase 3 study called INT-11. Specifically, patients with lymph node or liver metastases and those with no abdominal pain appear most likely to benefit. The data are being presented at the ASCO GI Cancers Symposium in San Francisco.</li><li>INT-11 enrolled 688 pancreatic cancer patients. Its primary objective was evaluating the effectiveness of tipifarnib + chemo agent gemcitabine compared to gemcitabine + placebo. Treatment with tipifarnib failed to show enough of an effect on overall survival &#40;OS&#41; in the overall population but did demonstrate longer median OS in patients with no abdominal pain (n=155) with 48% less risk of death (10.2 months vs. 5.9 months; hazard ratio = 0.52; p&lt;0.0001). The company says the absence of abdominal pain may serve as a surrogate of clinical benefit in these patients.</li><li>Tipifarnib also showed a treatment effect in patients (n=67) with nodal or distant (liver only) metastases. Median OS in the nodal group was 12.8 months vs. 8.2 months in the gemcitabine + placebo arm with 54% less risk of death (hazard ratio = 0.46; p=0.01) and 10.2 months vs. 5.9 months with 30% less risk of death (hazard ratio - 0.70; p=0.02) in the liver metastases group. The cancer in both groups expressed high levels of a gene called <a href=\"https://ghr.nlm.nih.gov/gene/CXCL12\" target=\"_blank\">CXCL12 </a>which the company says tipifarnib downregulates.</li><li><a href=\"http://www.kuraoncology.com/pipeline/tipifarnib-hras/\" target=\"_blank\">Tipifarnib </a>inhibits an enzyme called farnesyl transferase. Interfering with its function inhibits protein farnesylation, a key signaling process in cancer initiation and development. Farnesyl transferase inhibitors have shown particular promise in blocking HRAS (an oncogene) farnesylation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424302\" data-linked=\"Kura Oncology up 3% on encouraging tipifarnib data in pancreatic cancer\" data-tweet=\"$KURA - Kura Oncology up 3% on encouraging tipifarnib data in pancreatic cancer https://seekingalpha.com/news/3424302-kura-oncology-up-3-on-encouraging-tipifarnib-data-in-pancreatic-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3424302-kura-oncology-up-3-on-encouraging-tipifarnib-data-in-pancreatic-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424301\" data-ts=\"1547827520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424301-22nd-century-group-and-cellectar-biosciences-among-healthcare-gainers-immunomedics-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">22nd Century Group and Cellectar Biosciences among healthcare gainers; Immunomedics and Microbot Medical among losers</a></h4><ul><li><b>Gainers: </b>Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) <font color=\"green\">+13%</font>. Rafael Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/RFL' title='Rafael Holdings, Inc.'>RFL</a>) <font color=\"green\">+11%</font>. EDAP TMS (NASDAQ:<a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a>) <font color=\"green\">+9%</font>. 22nd Century Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a>) <font color=\"green\">+9%</font>. Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc'>TOCA</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-35%</font>. Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) <font color=\"red\">-29%</font>. Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"red\">-22%</font>. Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"red\">-18%</font>. Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424301\" data-linked=\"22nd Century Group and Cellectar Biosciences among healthcare gainers; Immunomedics and Microbot Medical among losers\" data-tweet=\"$CLRB $CLRB $RFL - 22nd Century Group and Cellectar Biosciences among healthcare gainers; Immunomedics and Microbot Medical among losers https://seekingalpha.com/news/3424301-22nd-century-group-and-cellectar-biosciences-among-healthcare-gainers-immunomedics-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3424301-22nd-century-group-and-cellectar-biosciences-among-healthcare-gainers-immunomedics-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424292\" data-ts=\"1547826730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TME\" target=\"_blank\">TME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424292-tencent-musicplus-4_3-hsbc-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tencent Music +4.3% as HSBC starts at Buy</a></h4><ul>   <li>Tencent Music Entertainment ADRs (NYSE:<a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a>) are <font color=\"green\">up 4.3%</font> after a launch at Buy by HSBC.</li>    <li>The firm's Binnie Wong has set a price target to $16, now implying 18% upside.</li>    <li>The ADRs are only slightly above their IPO price; the offering priced at $13 last month, the bottom of their marketed range.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424292\" data-linked=\"Tencent Music +4.3% as HSBC starts at Buy\" data-tweet=\"$TME - Tencent Music +4.3% as HSBC starts at Buy https://seekingalpha.com/news/3424292-tencent-musicplus-4_3-hsbc-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3424292-tencent-musicplus-4_3-hsbc-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424291\" data-ts=\"1547826700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIMO\" target=\"_blank\">SIMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424291-silicon-motionplus-5-on-bofaml-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silicon Motion +5% on BofAML upgrade</a></h4><ul><li>Bank of America Merrill Lynch upgrades Silicon Motion (NASDAQ:<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a>) from Underperform to Buy. (Source: Bloomberg First Word)</li><li>Earlier this month, Silicon Motion <a href=\"https://seekingalpha.com/news/3421457-silicon-motion-minus-3-percent-lower-q4-preliminary-results\" target=\"_blank\">announced </a>preliminary Q4 results that pushed revenue to the lower end of the $120.5M to $127.5M guidance range. Silicon Motion will report earnings on January 30.</li><li>SIMO shares are <font color=\"red\">down 25%</font> in the past quarter and <font color=\"red\">32%</font> in the past six months, making the pullback a potential reason for upgrades.</li><li>SIMO shares are <font color=\"green\">up 4.8%</font> to $36.84.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424291\" data-linked=\"Silicon Motion +5% on BofAML upgrade\" data-tweet=\"$SIMO - Silicon Motion +5% on BofAML upgrade https://seekingalpha.com/news/3424291-silicon-motionplus-5-on-bofaml-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3424291-silicon-motionplus-5-on-bofaml-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424286\" data-ts=\"1547825383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424286-truckers-rally-off-another-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Truckers rally off another earnings topper</a></h4><ul>  <li>The trucking sector is another earnings rush again after J.B. Hunt Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color='green'>+6%</font>) blasts past estimates on impressive margin gains.</li> <li>\"Results were actually strong across its segments, especially in its truckload business, which saw margins improve by 600 basis points. JBHT\u2019s dedicated business benefited from new business and further expansion into last mile,\" notes Bloomberg Intelligence's Lee Klaskow on the JBHT print.</li><li>Notable gainers include Old Dominion Freight Line (<a href='https://seekingalpha.com/symbol/ODFL' title='Old Dominion Freight Line, Inc.'>ODFL</a> <font color='green'>+3.6%</font>), Hub Group (<a href='https://seekingalpha.com/symbol/HUBG' title='Hub Group, Inc.'>HUBG</a> <font color='green'>+4.1%</font>), Schneider National (<a href='https://seekingalpha.com/symbol/SNDR' title='Schneider National'>SNDR</a> <font color='green'>+2.4%</font>), Heartland Express (<a href='https://seekingalpha.com/symbol/HTLD' title='Heartland Express, Inc.'>HTLD</a> <font color='green'>+1.7%</font>), Landstar Systems (<a href='https://seekingalpha.com/symbol/LSTR' title='Landstar System, Inc.'>LSTR</a> <font color='green'>+2.7%</font>), Werner Enterprises (<a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color='green'>+2.5%</font>) and Knight-Swift Transportation (<a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a> <font color='green'>+2.1%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424281-j-b-hunt-transport-services-plus-6_8-percent-post-q4-results\" target=\"_blank\">J.B. Hunt Transport Services +6.8% post Q4 results</a> (Jan. 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423901-knight-swift-guidance-lifts-trucking-sector\" target=\"_blank\">Knight-Swift guidance lifts trucking sector</a> (Jan. 17)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424286\" data-linked=\"Truckers rally off another earnings topper\" data-tweet=\"$JBHT $JBHT $ODFL - Truckers rally off another earnings topper https://seekingalpha.com/news/3424286-truckers-rally-off-another-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3424286-truckers-rally-off-another-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424281\" data-ts=\"1547824971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424281-j-b-hunt-transport-servicesplus-6_8-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.B. Hunt Transport Services +6.8% post Q4 results</a></h4><div><ul><li>J.B. Hunt Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color=\"green\">+6.8%</font>) reports <a href=\"https://seekingalpha.com/pr/17384465-j-b-hunt-transport-services-inc-reports-revenues-net-earnings-earnings-per-share-fourth\" target=\"_blank\">Q4</a> revenue growth of 16.6% Y/Y to $2.32M.</li><li>A 16% increase in revenue/load in Intermodal contributed to +15% Y/Y in segment revenue to $1.26B.</li><li>Dedicated Contract Services segment revenue increased by 25% Y/Y to $596M, primarily from the addition of new customer accounts and improved asset utilization.</li><li>Integrated Capacity Solutions segment revenue increased by 7% Y/Y to $345M primarily from a 14% increase in load growth.</li><li>Truck segment revenue increased 21% Y/Y to $118M primarily from customer rate/mile increases.</li><li>Segment operating margin: Intermodal was 2.57%; Dedicated Contract Services was 9.97%; Integrated Capacity Solutions was 4.67% and Truck was 12.46%.</li><li>At December 31, 2018, total debt outstanding was $1.15B on various debt instruments; net Capex for 2018 ~$885M and cash &amp; equivalents of $7.6M.</li><li>The company purchased ~494K shares of common stock for ~$50M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424029-j-b-hunt-transport-services-misses-0_67-beats-revenue\" target=\"_blank\">J.B. Hunt Transport Services misses by $0.67, beats on revenue</a> (Jan. 17)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3424281\" data-linked=\"J.B. Hunt Transport Services +6.8% post Q4 results\" data-tweet=\"$JBHT - J.B. Hunt Transport Services +6.8% post Q4 results https://seekingalpha.com/news/3424281-j-b-hunt-transport-servicesplus-6_8-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3424281-j-b-hunt-transport-servicesplus-6_8-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424282\" data-ts=\"1547824871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424282-report-viacom-discussing-acquisition-of-pluto-tv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Viacom discussing acquisition of Pluto TV</a></h4><ul>   <li>Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color=\"green\">+1.4%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color=\"green\">+1.9%</font>) is in discussions to <a href=\"https://www.theinformation.com/articles/free-tv-with-ads-is-digital-medias-old-new-idea\" target=\"_blank\">acquire Pluto TV</a>, according to The Information.</li>    <li>That's a deal that could be valued between $300M and $500M, the report says.</li>    <li>Pluto TV is an ad-supported streaming service and a rival to Tubi TV, which Viacom is also <a href=\"https://seekingalpha.com/news/3422507-report-viacom-talks-acquire-streaming-service-tubi-tv\" target=\"_blank\">reportedly in talks to acquire</a>.</li>    <li>Pursuing both marks a strong move toward ad-supported free streaming for Viacom, against the tide of competitors moving toward subscription products.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424282\" data-linked=\"Report: Viacom discussing acquisition of Pluto TV\" data-tweet=\"$VIA $VIA $VIAB - Report: Viacom discussing acquisition of Pluto TV https://seekingalpha.com/news/3424282-report-viacom-discussing-acquisition-of-pluto-tv?source=tweet\" data-url=\"https://seekingalpha.com/news/3424282-report-viacom-discussing-acquisition-of-pluto-tv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424279\" data-ts=\"1547824508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424279-eli-lilly-to-stop-promoting-lartruvo-after-phase-3-flop-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eli Lilly to stop promoting Lartruvo after Phase 3 flop; shares down 3%</a></h4><ul><li>Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-3%</font>) has <a href=\"https://www.fiercepharma.com/pharma/as-lilly-works-to-gain-steam-oncology-its-lartruvo-takes-a-big-step-back\" target=\"_blank\">stopped promoting</a> LARTRUVO (olaratumab) for the treatment of soft tissue sarcoma after a Phase 3 clinical trial <a href=\"https://seekingalpha.com/news/3424174-lillys-olaratumab-flunks-late-stage-soft-tissue-sarcoma-study\" target=\"_blank\">failed to demonstrate </a>a treatment benefit over standard-of-care chemo.</li><li>It will book a pretax charge of $70M - 90M this quarter as it works through what to do next. The action will trim EPS this year by ~$0.17.</li><li>The FDA approved the med over two years under accelerated review status based on Phase 2 data that showed a positive effect.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424279\" data-linked=\"Eli Lilly to stop promoting Lartruvo after Phase 3 flop; shares down 3%\" data-tweet=\"$LLY - Eli Lilly to stop promoting Lartruvo after Phase 3 flop; shares down 3% https://seekingalpha.com/news/3424279-eli-lilly-to-stop-promoting-lartruvo-after-phase-3-flop-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3424279-eli-lilly-to-stop-promoting-lartruvo-after-phase-3-flop-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424277\" data-ts=\"1547824264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424277-zayoplus-6_1-on-report-p-e-group-looking-to-press-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zayo +6.1% on report P-E group looking to press purchase</a></h4><ul>   <li>Zayo Group (NYSE:<a href='https://seekingalpha.com/symbol/ZAYO' title='Zayo Group'>ZAYO</a>) is on the move, <font color=\"green\">up 6.1%</font> following word from dealReporter that a private-equity suitor group is trying to bring their deal to a close.</li>    <li>A consortium of Blackstone, Stonepeak, KKR, I Squared, GTCR and Charlesbank has been talking to bankers with an eye to closing the deal in coming weeks, according to dealReporter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424277\" data-linked=\"Zayo +6.1% on report P-E group looking to press purchase\" data-tweet=\"$ZAYO - Zayo +6.1% on report P-E group looking to press purchase https://seekingalpha.com/news/3424277-zayoplus-6_1-on-report-p-e-group-looking-to-press-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3424277-zayoplus-6_1-on-report-p-e-group-looking-to-press-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424276\" data-ts=\"1547824067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSU\" target=\"_blank\">KSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424276-rails-follow-kansas-city-southern-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rails follow Kansas City Southern higher</a></h4><ul> <li>Strong results from Kansas City Southern (<a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a> <font color='green'>+4.8%</font>) are providing a lift to the rails sector. The confident tone from Kansas City Southern on topline growth follows up on a CSX (<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a> <font color='green'>+2.5%</font>) earnings topper and positive  forecast from a few days ago.</li><li>Gainers include Norfolk Southern (<a href='https://seekingalpha.com/symbol/NSC' title='Norfolk Southern Corporation'>NSC</a> <font color='green'>+1.9%</font>), Union Pacific (<a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color='green'>+1.6%</font>), Canadian National Railway (<a href='https://seekingalpha.com/symbol/CNI' title='Canadian National Railway Company'>CNI</a> <font color='green'>+1%</font>) and Greenbrier (<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color='green'>+1.3%</font>).</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3424231-kansas-city-southern-tracks-higher-earnings\" target=\"_blank\">Kansas City Southern tracks higher after earnings</a> (Jan. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424276\" data-linked=\"Rails follow Kansas City Southern higher\" data-tweet=\"$KSU $KSU $CSX - Rails follow Kansas City Southern higher https://seekingalpha.com/news/3424276-rails-follow-kansas-city-southern-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3424276-rails-follow-kansas-city-southern-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424265\" data-ts=\"1547822963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZBH\" target=\"_blank\">ZBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424265-zimmer-biomet-down-1-on-cautious-mention-cleveland-research\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zimmer Biomet down 1% on cautious mention at Cleveland Research</a></h4><ul><li>Zimmer Biomet Holdings (<a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a> <font color=\"red\">-1%</font>) is under modest pressure in early trade in apparent response to a cautious report at independent equity research shop <a href=\"https://www.clevelandresearch.com/\" target=\"_blank\">Cleveland Research</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424265\" data-linked=\"Zimmer Biomet down 1% on cautious mention at Cleveland Research\" data-tweet=\"$ZBH - Zimmer Biomet down 1% on cautious mention at Cleveland Research https://seekingalpha.com/news/3424265-zimmer-biomet-down-1-on-cautious-mention-cleveland-research?source=tweet\" data-url=\"https://seekingalpha.com/news/3424265-zimmer-biomet-down-1-on-cautious-mention-cleveland-research\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424266\" data-ts=\"1547822943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424266-windstream-expanding-core-network-montreal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream expanding core network into Montreal</a></h4><ul>   <li>Windstream Wholesale (<a href=\"http://seekingalpha.com/symbol/WIN\" target=\"_blank\">WIN</a> <font color=\"green\">+2.9%</font>) will expand its core network <a href=\"https://seekingalpha.com/pr/17385100-windstream-wholesale-expands-long-haul-core-network-canada\" target=\"_blank\">by 200 miles into Montreal</a> using existing long-haul fiber assets.</li>    <li>That will connect Windstream's network within the Montreal ecosystem of Cologix, the market's leading data center operator.</li>    <li>Windstream will offer up to 100 Gbps Wavelength Services and 10 Gbps Internet/Ethernet services at the Montreal location, which will enable access to core U.S. routes terminating and connecting in major NYC peering locations as well as data centers and cable landing stations in Wall Township, N.J., and Ashburn, Va.</li>    <li>Services will be available in Q1 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424266\" data-linked=\"Windstream expanding core network into Montreal\" data-tweet=\"$WIN $WINMQ - Windstream expanding core network into Montreal https://seekingalpha.com/news/3424266-windstream-expanding-core-network-montreal?source=tweet\" data-url=\"https://seekingalpha.com/news/3424266-windstream-expanding-core-network-montreal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>115&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424262\" data-ts=\"1547822535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIN\" target=\"_blank\">KIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424262-kindred-prices-stock-offering-9_50-shares-down-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kindred prices stock offering at $9.50; shares down 8%</a></h4><ul><li>Kindred Biosciences (<a href='https://seekingalpha.com/symbol/KIN' title='Kindred Biosciences, Inc.'>KIN</a> <font color=\"red\">-8.2%</font>) is down on almost double normal in early trade in response to its <a href=\"https://seekingalpha.com/pr/17385107-kindred-biosciences-announces-pricing-public-offering\" target=\"_blank\">public offering</a> of 4.215M shares of common stock at $9.50 per share. Underwriters over-allotment is an additional ~632K shares. Closing date is January 23.</li><li>Yesterday's close was $10.71.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424262\" data-linked=\"Kindred prices stock offering at $9.50; shares down 8%\" data-tweet=\"$KIN - Kindred prices stock offering at $9.50; shares down 8% https://seekingalpha.com/news/3424262-kindred-prices-stock-offering-9_50-shares-down-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3424262-kindred-prices-stock-offering-9_50-shares-down-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424255\" data-ts=\"1547821780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424255-biocept-prices-2_2m-registered-direct-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept prices $2.2M registered direct offering</a></h4><ul> <li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) has <a href=\"https://seekingalpha.com/pr/17385034-biocept-announces-pricing-2_2-million-registered-direct-offering\" target=\"_blank\">entered</a> into a securities purchase agreement to sell ~990K common shares a price of $2.25 in a registered direct offering.</li>                  <li>Expected gross proceeds are ~$2.2M.</li><li>Closing date is January 23.</li><li>Shares are down <font color=\"red\">25%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3424255\" data-linked=\"Biocept prices $2.2M registered direct offering\" data-tweet=\"$BIOC - Biocept prices $2.2M registered direct offering https://seekingalpha.com/news/3424255-biocept-prices-2_2m-registered-direct-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424255-biocept-prices-2_2m-registered-direct-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424253\" data-ts=\"1547821705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424253-cevian-sees-ericsson-topping-margin-targets-in-5g-ramp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cevian sees Ericsson topping margin targets in 5G ramp</a></h4><ul>   <li>Ericsson (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a>) is <font color=\"green\">up 1.7%</font> in premarket U.S. trading after Lars Forberg, of Ericsson shareholder Cevian, says there's a \"huge opportunity\" for the company in the 5G ramp.</li>    <li>That's particularly true with Huawei having trouble reaching the market due to political issues, Forberg tells Bloomberg TV.</li>    <li>Ericsson can get to 20% operating margin \"and beyond\" in its networks business, he says -- above Ericsson's own 2020 target of 15-17% margin.</li>    <li>\"You have a growing market, where Ericsson is going to increase market share,\" he says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424253\" data-linked=\"Cevian sees Ericsson topping margin targets in 5G ramp\" data-tweet=\"$ERIC - Cevian sees Ericsson topping margin targets in 5G ramp https://seekingalpha.com/news/3424253-cevian-sees-ericsson-topping-margin-targets-in-5g-ramp?source=tweet\" data-url=\"https://seekingalpha.com/news/3424253-cevian-sees-ericsson-topping-margin-targets-in-5g-ramp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424252\" data-ts=\"1547821488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDAP\" target=\"_blank\">EDAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424252-edap-tms-up-13-premarket-on-focal-one-sale-in-ny\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EDAP TMS up 13% premarket on Focal One sale in NY</a></h4><ul><li>Thinly traded nano cap EDAP TMS SA (NASDAQ:<a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a>) is up <font color=\"green\">13% </font>premarket on light volume following its <a href=\"https://seekingalpha.com/pr/17384909-edap-tms-sa-edap-announces-purchase-focal-one-hifu-maimonides-medical-center-brooklyn-ny\" target=\"_blank\">announcement</a> that it has sold a Focal One HIFU device to the Maimonides Medical Center in Brooklyn, NY. The product is used to treat prostate cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424252\" data-linked=\"EDAP TMS up 13% premarket on Focal One sale in NY\" data-tweet=\"$EDAP - EDAP TMS up 13% premarket on Focal One sale in NY https://seekingalpha.com/news/3424252-edap-tms-up-13-premarket-on-focal-one-sale-in-ny?source=tweet\" data-url=\"https://seekingalpha.com/news/3424252-edap-tms-up-13-premarket-on-focal-one-sale-in-ny\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424250\" data-ts=\"1547821150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424250-gevo-vfc-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo, VFC among premarket gainers</a></h4><ul><li>Gevo (NASDAQ:<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a>) <font color=\"green\">+45%</font> on <a href=\"https://seekingalpha.com/pr/17384708-gevo-avfuel-partner-supply-sustainable-jet-fuel-business-jets-fuel-green-event-van-nuys\" target=\"_blank\">supplying</a> its sustainable and renewable alcohol-to-jet fuel to Avfuel.</li><li>Bank OZK (NASDAQ:<a href='https://seekingalpha.com/symbol/OZK' title='Bank OZK'>OZK</a>) <font color=\"green\">+15%</font> on Q4 <a href=\"https://seekingalpha.com/news/3424024-bank-ozk-beats-0_07-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>V.F. (NYSE:<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a>) <font color=\"green\">+9%</font> on Q3 <a href=\"https://seekingalpha.com/news/3424168-v-f-corp-beats-0_20-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>Gulfport Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a>) <font color=\"green\">+9%</font> after <a href=\"https://seekingalpha.com/news/3424075-gulfport-energy-plus-5-percent-launching-400m-stock-buyback-program\" target=\"_blank\">launching</a> $400M stock buyback program.</li><li>Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a>) <font color=\"green\">+8%</font> on Q2 <a href=\"https://seekingalpha.com/news/3424025-atlassian-beats-0_04-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>AcelRx Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424250\" data-linked=\"Gevo, VFC among premarket gainers\" data-tweet=\"$GEVO $GEVO $OZK - Gevo, VFC among premarket gainers https://seekingalpha.com/news/3424250-gevo-vfc-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424250-gevo-vfc-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424249\" data-ts=\"1547820985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424249-tsla-and-lxrx-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSLA and LXRX among premarket losers</a></h4><ul><li>Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-51%</font> on <a href=\"https://seekingalpha.com/news/3424226-tyme-48-percent-smminus-88-data\" target=\"_blank\">SM-88 data</a>.</li><li>Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>) <font color=\"red\">-43%</font> on <a href=\"https://seekingalpha.com/news/3424119-nautilus-minus-32-percent-q4-earnings-revenues-seen-far-expectations\" target=\"_blank\">issuing</a> downside Q4 guidance.</li><li>Casa Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a>) <font color=\"red\">-28%</font> <a href=\"https://seekingalpha.com/news/3424100-casa-systems-announces-preliminary-q4-fy18-results\" target=\"_blank\">announcing</a> preliminary results for Q4 and FY18.</li><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"red\">-29%</font> on <a href=\"https://seekingalpha.com/pr/17385034-biocept-announces-pricing-2_2-million-registered-direct-offering\" target=\"_blank\">pricing</a> $2.2M registered direct offering.</li><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"red\">-22%</font> after <a href=\"https://seekingalpha.com/news/3424198-lexicon-pharma-23-percent-premarket-split-ad-com-vote-sotagliflozin\" target=\"_blank\">split Ad Com vote</a> on sotagliflozin.</li><li>MannKind (NASDAQ:<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>) <font color=\"red\">-13%</font>.</li><li>ToughBuilt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"red\">-9%</font>.</li><li>Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) <font color=\"red\">-7%</font>.</li><li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color=\"red\">-7%</font> after <a href=\"https://seekingalpha.com/news/3424145-tesla-cuts-workforce-around-7-percent\" target=\"_blank\">slashing</a> workforce by around 7%.</li><li>CorMedix (NYSEMKT:<a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a>) <font color=\"red\">-5%</font>.</li><li>CVR Refining (NYSE:<a href='https://seekingalpha.com/symbol/CVRR' title='CVR Refining, LP'>CVRR</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3424109-cvr-energy-exercise-right-purchase-cvr-refining-units\" target=\"_blank\">announcing</a> exercise right to purchase all CVR Refining units.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424249\" data-linked=\"TSLA and LXRX among premarket losers\" data-tweet=\"$TYME $TYME $NLS - TSLA and LXRX among premarket losers https://seekingalpha.com/news/3424249-tsla-and-lxrx-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424249-tsla-and-lxrx-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424247\" data-ts=\"1547820914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FHN\" target=\"_blank\">FHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424247-first-horizon-nationalminus-1_6-after-q4-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Horizon National -1.6% after Q4 revenue miss</a></h4><ul><li>First Horizon National (NYSE:<a href='https://seekingalpha.com/symbol/FHN' title='First Horizon National Corporation'>FHN</a>) <font color=\"red\">slips 1.6%</font> in premarket trading after <a href=\"https://seekingalpha.com/pr/17384808-first-horizon-releases-2018-fourth-quarter-full-year-financial-results\" target=\"_blank\">Q4 revenue of $412.8M</a> misses estimate of $442.7M.</li><li>Q4 adjusted EPS of 35 cents match consensus estimate.</li><li>Remains optimistic about the economy \"based on the financial health of our current customers, their activity, and our ability to attract new business,\" says Chairman and CEO Bryan Jordan.</li><li>Total loans increased 1% Q/Q to $27.5B and essentially flat vs. a year ago.</li><li>Average core commercial loans rose by 5% from Q3, and period-end deposits rose 5%.</li><li>Q4 net interest income of $302.5M slips 1% from $305.7M in Q3 and up 25% from $242.1M in the year-ago period; net interest margin of 3.38% declines from 3.44% in Q3 and increases from 3.27% in Q4 2017.</li><li><strong>Sees 2019 NIM</strong> in <a href=\"http://ir.fhnc.com/Cache/1500116712.PDF?O=PDF&amp;T=&amp;Y=&amp;D=&amp;FID=1500116712&amp;iid=100292\" target=\"_blank\">3.40%-3.50 range</a>, assuming the Fed raises rates in June and 3%-6% loan and deposit growth.</li><li>Common equity tier 1 ratio of 9.75% vs. 9.84% in Q3 and 8.88% a year ago.</li><li><a href=\"https://www.globenewswire.com/Tracker?data=4jHbojHMmm0ZCAC7CwmGWgB3m-UfJwFfcYfwZZG0JE8e57j6BG6rdAXGxO0Xbw3INT5AM0WerRVyoDUhQMEbow==\" target=\"_blank\">Conference call</a> at 9:30 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424160-first-horizon-national-eps-line-misses-revenue\" target=\"_blank\">First Horizon National EPS in-line, misses on revenue</a> (Jan. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424247\" data-linked=\"First Horizon National -1.6% after Q4 revenue miss\" data-tweet=\"$FHN - First Horizon National -1.6% after Q4 revenue miss https://seekingalpha.com/news/3424247-first-horizon-nationalminus-1_6-after-q4-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3424247-first-horizon-nationalminus-1_6-after-q4-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424246\" data-ts=\"1547820647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424246-tesla-sheds-5-after-profit-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla sheds 5% after profit warning</a></h4><ul> <li>Wedbush is quick out of the gate with a note dissecting Tesla's (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) profit announcement this morning.</li> <li>Analyst Dan Ives acknowledges the \"clear challenges\" for the company with production targets and sustainable profit, but warns investors against a knee jerk reaction.</li> <li>\"Helping neutralize the expected US softness will be Europe and Asia demand with deliveries in Europe expected to hit the ground in late Feb/early March once homologation and other approvals are officially done,\" he writes.</li> <li>\"While headwinds are abound on a number of different fronts, we continue to believe Tesla will be able to emerge from the next 12 to 18 months a stronger, profitable more product diversified (geographically and price points) EV company helping lay the groundwork for Model 3 as a linchpin of growth going forward into 2020 and beyond,\" he adds.</li> <li>Wedbush sticks with an Outperform rating on Tesla.</li> <li>Oppenheimer and RBC Capital have also made media <a href=\"https://www.cnbc.com/2019/01/18/wall-street-bullish-on-tesla-as-job-cuts-signal-productivity-gains.html\" target=\"_blank\">appearances</a> this morning, with both firms taking the angle that the jobs cuts by Tesla weren't a big surprise amid the company's efforts to increase efficiency.</li><li>On the other side of the trade is Citi sitting with a Sell rating on the EV automaker. Citi's quickfire analysis on today's Tesla news is that its concerns on profit sustainability have been confirmed.</li> <li>Shares of Tesla are <font color=\"red\">down 5.35%</font> on premarket volume of over 770K shares.</li><li>Sources: CNBC, Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424145-tesla-cuts-workforce-around-7-percent\" target=\"_blank\">Tesla cuts workforce by around 7%</a> (Jan. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424246\" data-linked=\"Tesla sheds 5% after profit warning\" data-tweet=\"$TSLA - Tesla sheds 5% after profit warning https://seekingalpha.com/news/3424246-tesla-sheds-5-after-profit-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3424246-tesla-sheds-5-after-profit-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>324&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424245\" data-ts=\"1547820213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPL\" target=\"_blank\">UPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424245-ultra-petroleumplus-56-on-favorable-ruling-in-make-whole-litigation-appeal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultra Petroleum +56% on favorable ruling in make-whole litigation appeal</a></h4><ul><li>Ultra Petroleum (NASDAQ:<a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a>) <font color=\"green\">+56.6%</font> pre-market following news that the Fifth U.S. Circuit Court of Appeals delivered a <a href=\"https://seekingalpha.com/pr/17384711-ultra-petroleum-corp-announces-favorable-opinion-company-make-whole-litigation-appeal\" target=\"_blank\">favorable ruling</a> in the appeal proceedings about make-whole claims that had been asserted against the company.</li><li>UPL says the ruling reverses a bankruptcy court decision that had required it to  pay ~$400M to various creditors following the company\u2019s emergence from Chapter 11 proceedings.</li><li>UPL says it believes the outcome of any final decision will be consistent with  the Fifth Circuit ruling, which would result in the recovery of as much as $260M in non-settled claims the company previously paid to various  creditors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424245\" data-linked=\"Ultra Petroleum +56% on favorable ruling in make-whole litigation appeal\" data-tweet=\"$UPL $UPLC - Ultra Petroleum +56% on favorable ruling in make-whole litigation appeal https://seekingalpha.com/news/3424245-ultra-petroleumplus-56-on-favorable-ruling-in-make-whole-litigation-appeal?source=tweet\" data-url=\"https://seekingalpha.com/news/3424245-ultra-petroleumplus-56-on-favorable-ruling-in-make-whole-litigation-appeal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>93&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424234\" data-ts=\"1547819943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIPT\" target=\"_blank\">AIPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424234-precision-therapeutics-ceo-invests-another-1m-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Precision Therapeutics CEO invests another $1M; shares up 3% premarket</a></h4><ul> <li>Precision Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AIPT' title='Precision Therapeutics Inc.'>AIPT</a>) CEO and Director Carl Schwartz has <a href=\"https://seekingalpha.com/pr/17385010-precision-therapeutics-receives-1370-000-investment-ceo-director-carl-schwartz\" target=\"_blank\">invested</a> an additional $1M in the company, a $950K loan and the purchase of 78,125 common shares at $0.64 per share.</li><li>He also received additional warrants to purchase common stock.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3424234\" data-linked=\"Precision Therapeutics CEO invests another $1M; shares up 3% premarket\" data-tweet=\"$AIPT $POAI - Precision Therapeutics CEO invests another $1M; shares up 3% premarket https://seekingalpha.com/news/3424234-precision-therapeutics-ceo-invests-another-1m-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3424234-precision-therapeutics-ceo-invests-another-1m-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424231\" data-ts=\"1547819384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSU\" target=\"_blank\">KSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424231-kansas-city-southern-tracks-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kansas City Southern tracks higher after earnings</a></h4><ul> <li>Kansas City Southern (NYSE:<a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a>) is <font color=\"green\">up 1.5%</font> in premarket trading after topping estimates on both lines of its Q4 report.</li> <li>The company reports an operating ratio of 64.3% in Q4 vs. 64.0% a year ago and 63.9% consensus.</li> <li>\"While we delivered record revenues, adjusted operating income and adjusted EPS, 2018 did not meet our own expectations for financial or operational performance. In addition, we did not meet the expectations of our customers or shareowners, particularly in the areas of customer service and growth,\" says Kansas City Southern CEO Patrick Ottensmeyer.</li> <li>Ottensmeyer and the rest of the KSU management team stick with an outlook for a company operating ratio target of 60% to 61% by the year 2021.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424211-kansas-city-southern-beats-0_03-beats-revenue\" target=\"_blank\">Kansas City Southern beats by $0.03, beats on revenue</a> (Jan. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424231\" data-linked=\"Kansas City Southern tracks higher after earnings\" data-tweet=\"$KSU - Kansas City Southern tracks higher after earnings https://seekingalpha.com/news/3424231-kansas-city-southern-tracks-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3424231-kansas-city-southern-tracks-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424229\" data-ts=\"1547819353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CANF\" target=\"_blank\">CANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424229-can-fite-bio-down-8-premarket-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Can-Fite Bio down 8% premarket on equity offering</a></h4><ul> <li>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) is down <font color=\"red\">8%</font> premarket in response to its <a href=\"https://seekingalpha.com/pr/17384927-can-fite-biopharma-announces-registered-direct-offering\" target=\"_blank\">direct sale</a> of 2,238,096 ADSs at $1.05/ADS to an institutional investor.</li><li>The investor will also receive 5 1/2-year warrants to purchase up to the same number of ADSs at $1.30.</li><li>Closing date is January 23.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3424229\" data-linked=\"Can-Fite Bio down 8% premarket on equity offering\" data-tweet=\"$CANF - Can-Fite Bio down 8% premarket on equity offering https://seekingalpha.com/news/3424229-can-fite-bio-down-8-premarket-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424229-can-fite-bio-down-8-premarket-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424230\" data-ts=\"1547819344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424230-alibaba-postpones-hiring-cuts-travel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba postpones hiring, cuts travel</a></h4><ul><li>Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) will postpone some hiring and cut travel spending to prepare with the slowing economy, according to <a href=\"https://www.bloomberg.com/news/articles/2019-01-18/alibaba-is-said-to-postpone-some-hiring-cut-travel-spending\" target=\"_blank\">Bloomberg sources</a>.</li><li>New hires were told they couldn't start until the new fiscal year begins in April. Traveling staff can only select a premium cabin on every fifth trip that takes more than 20 hours.</li><li>The continuing US-China trade tensions and ebbing consumer spending have analysts predicting a slowdown for China's tech sector.</li><li>Alibaba shares are <font color=\"green\">up 1.4%</font> to $158.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424230\" data-linked=\"Alibaba postpones hiring, cuts travel\" data-tweet=\"$BABA - Alibaba postpones hiring, cuts travel https://seekingalpha.com/news/3424230-alibaba-postpones-hiring-cuts-travel?source=tweet\" data-url=\"https://seekingalpha.com/news/3424230-alibaba-postpones-hiring-cuts-travel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424226\" data-ts=\"1547818650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424226-tyme-down-48-on-smminus-88-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme down 48% on SM-88 data</a></h4><ul><li>Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) slumps <font color=\"red\">48%</font> premarket on light volume (so far) following its <a href=\"https://seekingalpha.com/news/3424215-tymes-smminus-88-improved-survival-mid-stage-pancreatic-cancer-study\" target=\"_blank\">release </a>of mid-stage data on SM-88 in patients with end-stage pancreatic cancer.</li><li>The company <a href=\"https://seekingalpha.com/pr/17384944-tyme-s-novel-metabolic-based-cancer-therapy-smminus-88-improves-survival-phase-ii-study\" target=\"_blank\">reported </a>a survival benefit in a third-line setting but investors aren't buying it.</li><li>STATnews' Adam Feuerstein <a href=\"https://twitter.com/adamfeuerstein/status/1086248324880130048\" target=\"_blank\">calls </a>the company's press release \"totally irresponsible,\" adding that the trial failed to show said survival benefit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424226\" data-linked=\"Tyme down 48% on SM-88 data\" data-tweet=\"$TYME - Tyme down 48% on SM-88 data https://seekingalpha.com/news/3424226-tyme-down-48-on-smminus-88-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3424226-tyme-down-48-on-smminus-88-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424221\" data-ts=\"1547818180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424221-suntrustplus-4_9-on-q4-beat-helped-cre-income\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust +4.9% on Q4 beat, helped by CRE income</a></h4><ul><li>SunTrust Banks <font color=\"green\">gains 4.9%</font> in premarket trading after<a href=\"https://seekingalpha.com/pr/17384801-suntrust-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\"> Q4 adjusted EPS of $1.50 </a>beats the average analyst estimate of  $1.37; compares with $1.42 in Q3 and $1.09 in the year-ago period.</li><li>Q4 net interest margin-FTE of 3.27% was stable vs. Q3 as higher benchmark interest rates were generally offset by increased wholesale funding, given strong loan growth; compares with 3.17% in Q4 2017.</li><li>Q4 net interest income of $1.55B rose from $1.51B in Q3 and $1.43B in Q4 2017.</li><li>Q4 noninterest income of $818M rose from $782M in Q3, mostly due to higher commercial real estate-related income, partly offset by lower capital markets-related income.</li><li>Average loans held for investment $149.7B vs. $146.0B in Q3 and $144.0B in Q4 2017; net charge-offs to total average LHFI (annualized) was 0.26% vs. 0.24% in Q3 and 0.29% in the year-ago quarter.</li><li>Common Equity Tier 1 of 9.21% vs. 9.60% in Q3 and 9.74% in Q4 2017.</li><li>Book value per common share of $49.57 at Dec. 31, 2018 vs. $47.94 at Dec. 31, 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424151-suntrust-banks-beats-0_13-beats-revenue\" target=\"_blank\">SunTrust Banks beats by $0.13, beats on revenue</a> (Jan. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424221\" data-linked=\"SunTrust +4.9% on Q4 beat, helped by CRE income\" data-tweet=\"SunTrust +4.9% on Q4 beat, helped by CRE income https://seekingalpha.com/news/3424221-suntrustplus-4_9-on-q4-beat-helped-cre-income?source=tweet\" data-url=\"https://seekingalpha.com/news/3424221-suntrustplus-4_9-on-q4-beat-helped-cre-income\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424220\" data-ts=\"1547818120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424220-gamestopplus-5-after-holiday-sales-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop +5% after holiday sales update</a></h4><ul> <li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) reports sales during the nine-week holiday period fell 5% to $2.63B.</li>   <li>Comparable store sales increased 1.5%, including a 3.6% increase in the U.S. partially offset by a 3.1% decrease internationally. The retailer says primary contributor to the difference between the increase in comparable store sales and the decrease in total company sales is the shift in the company\u2019s fiscal calendar for the 53<sup>rd</sup> week in FY17 and the timing of the Call of Duty launch.</li>  <li>\"Our comp performance was driven by strong sales in accessories, collectibles and digital which more than offset the decline in pre-owned sales and new video game hardware sales,\" says GameStop CFO/COO Rob Lloyd.</li>  <li>New hardware sales decreased 6.1% off a tough comparable a year ago that included the Xbox One X launch. Sales of new video game software decreased 8.3%. Collectibles sales increased 3.7%</li><li>GameStop reiterates its prior guidance for FY18 EPS of $2.55 to $2.75 vs. $2.66 consensus.</li><li>GME  <font color=\"green\">+4.63%</font> premarket to  $16.50.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17384916-gamestop-reports-2018-holiday-sales-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424220\" data-linked=\"GameStop +5% after holiday sales update\" data-tweet=\"$GME - GameStop +5% after holiday sales update https://seekingalpha.com/news/3424220-gamestopplus-5-after-holiday-sales-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3424220-gamestopplus-5-after-holiday-sales-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424215\" data-ts=\"1547818010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424215-tymes-smminus-88-improved-survival-in-mid-stage-pancreatic-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme&#39;s SM-88 improved survival in mid-stage pancreatic cancer study</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17384944-tyme-s-novel-metabolic-based-cancer-therapy-smminus-88-improves-survival-phase-ii-study\" target=\"_blank\">Results </a>from an open-label Phase 2 clinical trial evaluating Tyme Technologies' (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) SM-88 in patients with end-stage pancreatic cancer showed a treatment benefit. The data are being presented today at the ASCO GI Cancers Symposium in San Francisco.</li><li>Specifically, 68% (n=19/28) of evaluable patients with actively progressing end-stage pancreatic cancer who received SM-88 alone remain alive after median follow-up of 4.3 months.</li><li>79% (n=11/14) of patients receiving SM-88 in a third-line setting remain alive after median follow-up of 4.7 months, more than twice as long as historical results.</li><li>The company plans pursue regulatory approval for third-line use.</li><li><a href=\"https://www.tymeinc.com/sm-88/what-is-sm-88/\" target=\"_blank\">SM-88</a> is a combination therapy that uses a proprietary dysfunctional tyrosine derivative to interrupt the metabolic processes of cancer cells, breaking down their defenses and making them vulnerable to oxidative stress and death.</li><li>Management will host a conference call this morning at 9:00 am ET to discuss the data.</li><li>Shares, currently halted, will resume trading at 8:30 am ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3412149-tyme-tech-16-percent-ahead-data-readout-smminus-88-pancreatic-cancer\" target=\"_blank\">Tyme Tech up 16% ahead of data readout on SM-88 in pancreatic cancer</a> (Nov. 26, 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424215\" data-linked=\"Tyme&#39;s SM-88 improved survival in mid-stage pancreatic cancer study\" data-tweet=\"$TYME - Tyme&#39;s SM-88 improved survival in mid-stage pancreatic cancer study https://seekingalpha.com/news/3424215-tymes-smminus-88-improved-survival-in-mid-stage-pancreatic-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3424215-tymes-smminus-88-improved-survival-in-mid-stage-pancreatic-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424219\" data-ts=\"1547817904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPTH\" target=\"_blank\">BPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424219-bio-path-reverse-split-shares-1-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bio-Path reverse split shares 1:20</a></h4><ul><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <a href=\"https://seekingalpha.com/pr/17384901-bio-path-holdings-announces-1minus-20-reverse-stock-split\" target=\"_blank\">executed</a> a 1:20 reverse stock split after the close yesterday. Post-split trading commences today.</li><li><strong>Update</strong>: Shares are up <font color=\"green\">15%</font> premarket on modestly higher volume.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3424219\" data-linked=\"Bio-Path reverse split shares 1:20\" data-tweet=\"$BPTH - Bio-Path reverse split shares 1:20 https://seekingalpha.com/news/3424219-bio-path-reverse-split-shares-1-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3424219-bio-path-reverse-split-shares-1-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424213\" data-ts=\"1547816751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYAAY\" target=\"_blank\">RYAAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424213-ryanair-lowers-profit-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ryanair lowers profit forecast</a></h4><ul> <li>Ryanair (NASDAQ:<a href='https://seekingalpha.com/symbol/RYAAY' title='Ryanair Holdings PLC'>RYAAY</a>) lowers its forecast due in part to the expectation for lower winter fares.</li> <li>The Irish airline now expects profit after tax for the full fiscal year of between \u20ac1B euros and \u20ac1.1B vs. \u20ac1.1B to \u20ac1.2B prior estimate.</li> <li>CEO update: \"While we are disappointed at this slightly lower full year guidance, the fact that it is the direct result of lower than expected H2 air fares, offset by stronger than expected traffic growth, a better than expected performance on unit cost and ancillary sales is positive for the medium term. There is short haul over capacity in Europe this winter, but Ryanair continues to pursue our price passive/load factor active strategy to the benefit of our customers who are enjoying record lower air fares. We believe this lower fare environment will continue to shake out more loss making competitors, with WOW, Flybe, and reportedly Germania for example, all currently for sale.\"</li> <li><a href=\"https://investor.ryanair.com/wp-content/uploads/2019/01/January-2019-Trading-Update.pdf\" target=\"_blank\">Ryanair press release</a></li> <li>Shares of Rynair are <font color=\"red\">down 2.30%</font> in Dublin trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424213\" data-linked=\"Ryanair lowers profit forecast\" data-tweet=\"$RYAAY - Ryanair lowers profit forecast https://seekingalpha.com/news/3424213-ryanair-lowers-profit-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3424213-ryanair-lowers-profit-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424212\" data-ts=\"1547816673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STT\" target=\"_blank\">STT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424212-state-street-jumps-8_2-amid-plan-to-cut-1500-jobs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">State Street jumps 8.2% amid plan to cut 1,500 jobs</a></h4><ul><li>State Street (NYSE:<a href='https://seekingalpha.com/symbol/STT' title='State Street Corporation'>STT</a>)<font color=\"green\"> jumps 8.2%</font> after announcing it's plans to cut about 6% of its workforce, or about 1,500 jobs, to cut costs.</li><li><a href=\"https://seekingalpha.com/pr/17384863-state-street-reports-fourth-quarter-2018-eps-1_04-eps-1_68-excluding-notable-items\" target=\"_blank\">Q4 adjusted EPS </a>of $1.68 beats consensus estimate by a penny.</li><li>\"Amidst challenging market and industry headwinds, we have launched a new expense program designed to reduce costs,\" says President and CEO Ronald O'Hanley. \"As part of that program, we recorded a $223M pretax repositioning charge, the benefits of which we expect to fully realize within 12-15 months.\"</li><li>The new cost-cutting program includes cutting the number of senior managers by 15%.</li><li>Q4 net interest income of $697 rose 3.7% from Q3 and 13% from the year-ago period; net interest margin of 1.55% vs. 1.48% in Q3 and 1.38% in the year-ago quarter.</li><li>Assets under custody and administration $31.6T, down 7.0% from Q3 and down 4.5% from Q4 2017.</li><li>Assets under management of $2.51T declines 11% from Q3 and 9.7% from Q4 2017; during the quarter, AUM declined from total net outflows of $47B and market depreciation of $248B.</li><li>Average total assets $221.4B vs. $22.3B in Q3 and $216.3B in Q4 2017.</li><li>Return on average common equity 7.5% vs. 14.0% in Q3 and 6.9% in Q4 2017.</li><li><a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Finvestors.statestreet.com%2F&amp;esheet=51927617&amp;newsitemid=20190118005174&amp;lan=en-US&amp;anchor=http%3A%2F%2Finvestors.statestreet.com%2F&amp;index=1&amp;md5=b9dd324fcea56b02773df702450a0231\" target=\"_blank\">Conference call</a> at 10:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424183-state-street-beats-0_01-beats-revenue\" target=\"_blank\">State Street beats by $0.01, beats on revenue</a> (Jan. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424212\" data-linked=\"State Street jumps 8.2% amid plan to cut 1,500 jobs\" data-tweet=\"$STT - State Street jumps 8.2% amid plan to cut 1,500 jobs https://seekingalpha.com/news/3424212-state-street-jumps-8_2-amid-plan-to-cut-1500-jobs?source=tweet\" data-url=\"https://seekingalpha.com/news/3424212-state-street-jumps-8_2-amid-plan-to-cut-1500-jobs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424210\" data-ts=\"1547816668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424210-tyme-tech-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme Tech shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) pending the release of news. Shares were down <font color=\"red\">2%</font> premarket when halted.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424210\" data-linked=\"Tyme Tech shares halted pending news\" data-tweet=\"$TYME - Tyme Tech shares halted pending news https://seekingalpha.com/news/3424210-tyme-tech-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3424210-tyme-tech-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424198\" data-ts=\"1547816477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424198-lexicon-pharma-down-23-premarket-after-split-ad-com-vote-on-sotagliflozin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon Pharma down 23% premarket after split Ad Com vote on sotagliflozin</a></h4><ul><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) slumps <font color=\"red\">23%</font> premarket on light volume in reaction to yesterday's <a href=\"https://seekingalpha.com/news/3424048-ad-com-splits-vote-sanofi-lexicons-sotagliflozin\" target=\"_blank\">8-8 split vote</a> from a FDA advisory committee on sotagliflozin, making FDA approval highly uncertain.</li><li>Collaboration partner Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) is down <font color=\"red\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424198\" data-linked=\"Lexicon Pharma down 23% premarket after split Ad Com vote on sotagliflozin\" data-tweet=\"$LXRX $LXRX $SNY - Lexicon Pharma down 23% premarket after split Ad Com vote on sotagliflozin https://seekingalpha.com/news/3424198-lexicon-pharma-down-23-premarket-after-split-ad-com-vote-on-sotagliflozin?source=tweet\" data-url=\"https://seekingalpha.com/news/3424198-lexicon-pharma-down-23-premarket-after-split-ad-com-vote-on-sotagliflozin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424197\" data-ts=\"1547816471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424197-schlumbergerplus-3-after-in-line-q4-earnings-foresees-international-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schlumberger +3% after in-line Q4 earnings; foresees international growth</a></h4><ul><li>Schlumberger (NYSE:<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a>) <font color=\"green\">+3.1%</font> pre-market after reporting in-line <a href=\"https://seekingalpha.com/news/3424173-schlumberger-eps-line-beats-revenue\" target=\"_blank\">Q4 earnings</a> and flat revenues.</li><li>SLB says Q4 North America revenue of $2.8B fell 12% Q/Q, driven by lower activity and pricing for most production- and Cameron-related businesses in North America land; OneStim revenue dropped 25% as the company warm-stacked a number of fleets during the latter part of the quarter.</li><li>Q4 International revenue of $5.3B edged 1% higher Q/Q, as the seasonal slowdown in Russia was offset by increased revenue in the Middle East, Asia and Africa.</li><li>SLB expects a more positive supply and       demand balance sentiment to lead to a gradual recovery in the price of       oil over the course of 2019, but says oil price volatility has raised uncertainty around the E&amp;P spending outlook and customers are taking a generally more conservative approach to start the new year.</li><li>\"Even with the current oil prices, we       expect solid, single-digit growth in the international markets while in       North America land, the increased cost of capital and focus on aligning       investments closer to free cash flow has introduced more uncertainty to       the outlook for both drilling and production activity,\" the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424197\" data-linked=\"Schlumberger +3% after in-line Q4 earnings; foresees international growth\" data-tweet=\"$SLB - Schlumberger +3% after in-line Q4 earnings; foresees international growth https://seekingalpha.com/news/3424197-schlumbergerplus-3-after-in-line-q4-earnings-foresees-international-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3424197-schlumbergerplus-3-after-in-line-q4-earnings-foresees-international-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424192\" data-ts=\"1547815719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424192-cvs-inks-new-pbm-contract-walmart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CVS inks new PBM contract with Walmart</a></h4><ul><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) and Walmart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) have <a href=\"https://seekingalpha.com/pr/17384810-cvs-health-walmart-announce-new-pbm-pharmacy-network-agreement\" target=\"_blank\">inked</a> a new multi-year agreement under which latter will continue participating in the CVS Caremark pharmacy benefit management commercial and Managed Medicaid retail pharmacy networks.</li><li>Financial terms are not disclosed.</li><li>CVS is up <font color=\"green\">2%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424192\" data-linked=\"CVS inks new PBM contract with Walmart\" data-tweet=\"$CVS $CVS $WMT - CVS inks new PBM contract with Walmart https://seekingalpha.com/news/3424192-cvs-inks-new-pbm-contract-walmart?source=tweet\" data-url=\"https://seekingalpha.com/news/3424192-cvs-inks-new-pbm-contract-walmart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424193\" data-ts=\"1547815660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASA\" target=\"_blank\">CASA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424193-analysts-cut-casa-on-prelim-q4-disappointment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts cut Casa on prelim. Q4 disappointment</a></h4><ul><li>Morgan Stanley downgrades Casa Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a>) from Overweight to Equal-Weight and drops the target from $18 to $11, matching the Street-low target.</li><li>The firm says the bear case is playing out despite \"reasons to get excited\" about the wireless business.</li><li>More action: Raymond James lowers its CASA target from $19 to $17 saying that management's \"credibility with investors has suffered, and this latest miss delays the rebuilding process.\"</li><li>Source: Bloomberg First Word.</li><li>CASA shares are <font color=\"red\">down 30.5%</font> premarket to $10.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424100-casa-systems-announces-preliminary-q4-fy18-results\" target=\"_blank\">Casa Systems announces preliminary Q4 and FY18 results</a> (Jan. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424193\" data-linked=\"Analysts cut Casa on prelim. Q4 disappointment\" data-tweet=\"$CASA - Analysts cut Casa on prelim. Q4 disappointment https://seekingalpha.com/news/3424193-analysts-cut-casa-on-prelim-q4-disappointment?source=tweet\" data-url=\"https://seekingalpha.com/news/3424193-analysts-cut-casa-on-prelim-q4-disappointment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424187\" data-ts=\"1547815119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACB\" target=\"_blank\">ACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424187-aurora-cannabis-up-3-on-pricing-300m-convertible-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurora Cannabis up 3% on pricing $300M convertible debt offering</a></h4><ul> <li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <a href=\"https://seekingalpha.com/pr/17384851-aurora-cannabis-prices-offering-convertible-senior-notes\" target=\"_blank\">prices</a> its 5.5% convertible senior notes due 2024 at par. The Company will issue $300M aggregate principal amount of notes, or $345M if the initial purchasers' over-allotment option is exercised in full.</li>  <li>The initial conversion rate will be 138.37 common shares per $1,000 principal amount of notes (~$7.23/share).</li><li>Net proceeds will be used to support its Canadian and international expansion initiatives, for general corporate purposes and working capital.</li>  <li>Closing date is January 24.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3424187\" data-linked=\"Aurora Cannabis up 3% on pricing $300M convertible debt offering\" data-tweet=\"$ACB - Aurora Cannabis up 3% on pricing $300M convertible debt offering https://seekingalpha.com/news/3424187-aurora-cannabis-up-3-on-pricing-300m-convertible-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424187-aurora-cannabis-up-3-on-pricing-300m-convertible-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424186\" data-ts=\"1547814902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VFC\" target=\"_blank\">VFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424186-v-f-corpplus-10-after-strong-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">V.F. Corp +10% after strong earnings</a></h4><ul> <li>V.F. Corporation (NYSE:<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a>) shoots higher after posting strong results. The company reports active segment revenue jumped 16% in <a href=\"https://seekingalpha.com/pr/17384827-vf-reports-third-quarter-fiscal-2019-results-raises-full-year-fiscal-2019-outlook\" target=\"_blank\">FQ3</a> and international revenue rose 5%. Direct-to-consumer revenue was up 10%, lifted higher by 24% pop in digital revenue.</li><li>Gross margin was up 60 bps Y/Y to 52.2% of sales during the quarter. Adjusted operating margin was up 280 bps to 16.8% of sales.</li>  <li>Looking ahead, the company expects full-year 2019 revenue growth of over 12% and 2019 EPS of $3.73.</li> <li>Shares of V.F. Corp are <font color=\"green\">up 10.43%</font> in premarket trading to $80.90.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424168-v-f-corp-beats-0_20-beats-revenue\" target=\"_blank\">V.F. Corp beats by $0.20, beats on revenue</a> (Jan. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424186\" data-linked=\"V.F. Corp +10% after strong earnings\" data-tweet=\"$VFC - V.F. Corp +10% after strong earnings https://seekingalpha.com/news/3424186-v-f-corpplus-10-after-strong-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3424186-v-f-corpplus-10-after-strong-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424182\" data-ts=\"1547814718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424182-aristaplus-1_5-nomura-says-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arista +1.5% as Nomura says Buy</a></h4><ul><li>Nomura upgrades Arista Networks (NYSE:<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>) from Neutral to Buy citing the recent pullback and expectations of a strong Q4 that would hint at \"robust growth\" this year.</li><li>The firm says Arista is \"on track\" for Nomura's 2020 EPS estimate of $11.06.</li><li>Source: Bloomberg First Word.</li><li>ANET shares are <font color=\"green\">up 1.5%</font> premarket to $224.28.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424182\" data-linked=\"Arista +1.5% as Nomura says Buy\" data-tweet=\"$ANET - Arista +1.5% as Nomura says Buy https://seekingalpha.com/news/3424182-aristaplus-1_5-nomura-says-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3424182-aristaplus-1_5-nomura-says-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424178\" data-ts=\"1547813826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVRO\" target=\"_blank\">AVRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424178-fda-accepts-avrobios-ind-for-avr-rdminus-04\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts AVROBIO&#39;s IND for AVR-RD-04</a></h4><ul><li>AVROBIO (NASDAQ:<a href='https://seekingalpha.com/symbol/AVRO' title='AVROBIO'>AVRO</a>) will <a href=\"https://seekingalpha.com/pr/17384850-avrobio-inc-announces-acceptance-investigational-new-drug-ind-application-investigator\" target=\"_blank\">begin</a> a Phase 1/2 clinical trial for AVR-RD-04, for the treatment of cystinosis, following IND acceptance by FDA.</li>   <li>AVR\u2011RD-04 is designed as one-time gene therapy for the treatment of cystinosis by inserting the functional gene for human cystinosin &#40;CTNS&#41;.</li><li>Cystinosis is a rare, genetic, lysosomal storage disease caused by the accumulation of the amino acid cystine which can lead to organ and tissue damage.</li><li><strong>Update</strong>: Shares are up <font color=\"green\">11%</font> premarket albeit on only 70 shares.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3424178\" data-linked=\"FDA accepts AVROBIO&#39;s IND for AVR-RD-04\" data-tweet=\"$AVRO - FDA accepts AVROBIO&#39;s IND for AVR-RD-04 https://seekingalpha.com/news/3424178-fda-accepts-avrobios-ind-for-avr-rdminus-04?source=tweet\" data-url=\"https://seekingalpha.com/news/3424178-fda-accepts-avrobios-ind-for-avr-rdminus-04\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424175\" data-ts=\"1547813000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIG\" target=\"_blank\">SIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424175-citi-expects-damage-signet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi expects more damage at Signet</a></h4><ul> <li>Citi lowers Signet Jewelers (NYSE:<a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a>) to a Sell rating from Neutral following the retailer's devastating holiday sales report yesterday and cut in guidance.</li> <li>The firm thinks Signet's EBITDA will move even lower after already falling 55% from its peak in 2016.</li> <li>Citi slashes its price target on Signet to $20 from $41.</li> <li>Shares of Signet are <font color=\"red\">down 2.55%</font> premarket to $24.49 after falling 24.67% yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423936-freefall-signet-holiday-dud\" target=\"_blank\">Freefall for Signet after holiday dud</a> (Jan. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424175\" data-linked=\"Citi expects more damage at Signet\" data-tweet=\"$SIG - Citi expects more damage at Signet https://seekingalpha.com/news/3424175-citi-expects-damage-signet?source=tweet\" data-url=\"https://seekingalpha.com/news/3424175-citi-expects-damage-signet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424174\" data-ts=\"1547812973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424174-lillys-olaratumab-flunks-late-stage-soft-tissue-sarcoma-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilly&#39;s olaratumab flunks late-stage soft tissue sarcoma study</a></h4><ul><li>Eli Lilly's (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) LARTRUVO (olaratumab), combined with the chemo agent doxorubicin, <a href=\"https://seekingalpha.com/pr/17384820-lilly-reports-results-phase-3-soft-tissue-sarcoma-study-lartruvo\" target=\"_blank\">failed to demonstrate</a> a treatment benefit compared to doxorubicin alone in a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02451943?titles=announce&amp;lead=eli+lilly&amp;phase=2&amp;rank=1\" target=\"_blank\">ANNOUNCE</a>, in patients with advanced/metastatic soft tissue sarcoma &#40;STS&#41;.</li><li>Specifically, the study did not meet the primary endpoint of overall survival &#40;OS&#41; in the full study population nor in the leiomyosarcoma sub-population. No difference in survival was observed between the study arms for either group.</li><li>Detailed results will be submitted for presentation at a future medica conference and for publication.</li><li>The FDA granted accelerated approval for LARTRUVO for STS in October 2016.</li><li>The company says the negative outcome will shave ~$0.17 off of its 2019 EPS guidance. Its minimum 2020 outlook will remain as is.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424174\" data-linked=\"Lilly&#39;s olaratumab flunks late-stage soft tissue sarcoma study\" data-tweet=\"$LLY - Lilly&#39;s olaratumab flunks late-stage soft tissue sarcoma study https://seekingalpha.com/news/3424174-lillys-olaratumab-flunks-late-stage-soft-tissue-sarcoma-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3424174-lillys-olaratumab-flunks-late-stage-soft-tissue-sarcoma-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424153\" data-ts=\"1547809634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424153-immunomedics-receives-crl-for-sacituzumab-govitecan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics receives CRL for sacituzumab govitecan</a></h4><ul> <li>Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) has <a href=\"https://seekingalpha.com/pr/17384734-immunomedics-receives-complete-response-letter-fda-sacituzumab-govitecan-biologics-license\" target=\"_blank\">received</a> a Complete Response Letter &#40;CRL&#41; from the FDA for its BLA seeking accelerated approval for sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.</li><li>The Company will host a conference call today at 8:00 am ET to discuss the rejection.</li><li>Shares, currently halted, will resume trading at 9:10 am ET.</li><li><strong>Update</strong>: Shares are down <font color=\"red\">35%</font> premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3424153\" data-linked=\"Immunomedics receives CRL for sacituzumab govitecan\" data-tweet=\"$IMMU - Immunomedics receives CRL for sacituzumab govitecan https://seekingalpha.com/news/3424153-immunomedics-receives-crl-for-sacituzumab-govitecan?source=tweet\" data-url=\"https://seekingalpha.com/news/3424153-immunomedics-receives-crl-for-sacituzumab-govitecan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424151\" data-ts=\"1547809386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STI\" target=\"_blank\">STI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424151-suntrust-banks-beats-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust Banks beats by $0.13, beats on revenue</a></h4><ul><li>SunTrust Banks (NYSE:<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a>): Q4 Non-GAAP EPS of $1.50 <span style=\"color:green\">beats by $0.13</span>; GAAP EPS of $1.40 <span style=\"color:green\">beats by $0.03</span>.</li><li>Revenue of $2.39B (+3.5% Y/Y) <font color=\"green\">beats by $30M</font>.</li><li>Shares <font color=\"green\">+1.5%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17384801-suntrust-reports-fourth-quarter-full-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424151\" data-linked=\"SunTrust Banks beats by $0.13, beats on revenue\" data-tweet=\"$STI - SunTrust Banks beats by $0.13, beats on revenue https://seekingalpha.com/news/3424151-suntrust-banks-beats-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3424151-suntrust-banks-beats-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424137\" data-ts=\"1547804382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424137-trade-war-hopes-lift-global-equities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade war hopes lift global equities</a></h4><ul><li>Responding to reports of a possible trade detente between the U.S. and China, stocks across the globe are continuing their climb higher.</li><li>On Thursday, the <i>WSJ</i> quoted Treasury Secretary Steven Mnuchin as saying Washington could ease tariffs on Beijing, although the suggestion faced pushback from U.S. Trade Representative Robert Lighthizer.</li><li>Earnings season remains in full swing, and investors today will also be watching figures on U.S. industrial production and consumer sentiment.</li><li><b>Asia:</b> Nikkei <font color=\"green\">+1.3%</font>; Hang Seng <font color=\"green\">+1.3%</font>; Shanghai <font color=\"green\">+1.4%</font>; Sensex flat.</li><li><b>Europe:</b> FTSE 100 <font color=\"green\">+1%</font>. CAC 30 <font color=\"green\">+1.2%</font>. DAX <font color=\"green\">+1%</font>.</li><li><b>U.S. futures:</b> Dow <font color=\"green\">+0.4%</font>; S&amp;P 500 <font color=\"green\">+0.3%</font>; Nasdaq <font color=\"green\">+0.4%</font>.</li><li>Oil is <font color=\"green\">up 0.6%</font> at $52.66/bbl, gold is <font color=\"red\">0.4% lower</font> at $1288/ounce and the 10-year Treasury yield is up 2 bps to 2.77%.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>, <a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>, <a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>, <a href='https://seekingalpha.com/symbol/SH' title='ProShares Short S&P 500 ETF'>SH</a>, <a href='https://seekingalpha.com/symbol/SSO' title='ProShares Ultra S&P 500 ETF'>SSO</a>, <a href='https://seekingalpha.com/symbol/VOO' title='Vanguard S&P 500 ETF'>VOO</a>, <a href='https://seekingalpha.com/symbol/SDS' title='ProShares UltraShort S&P 500 ETF'>SDS</a>, <a href='https://seekingalpha.com/symbol/IVV' title='iShares Core S&P 500 ETF'>IVV</a>, <a href='https://seekingalpha.com/symbol/SPXU' title='ProShares UltraPro Short S&P 500 ETF'>SPXU</a>, <a href='https://seekingalpha.com/symbol/TQQQ' title='ProShares UltraPro QQQ ETF'>TQQQ</a>, <a href='https://seekingalpha.com/symbol/UPRO' title='ProShares UltraPro S&P 500 ETF'>UPRO</a>, <a href='https://seekingalpha.com/symbol/PSQ' title='ProShares Short QQQ ETF'>PSQ</a>, <a href='https://seekingalpha.com/symbol/SPXL' title='Direxion Daily S&P 500 Bull 3x Shares ETF'>SPXL</a>, <a href='https://seekingalpha.com/symbol/RSP' title='Invesco S&P 500 Equal Weight ETF'>RSP</a>, <a href='https://seekingalpha.com/symbol/SPXS' title='Direxion Daily S&P 500 Bear 3x Shares ETF'>SPXS</a>, <a href='https://seekingalpha.com/symbol/SQQQ' title='ProShares UltraPro Short QQQ ETF'>SQQQ</a>, <a href='https://seekingalpha.com/symbol/QID' title='ProShares UltraShort QQQ ETF'>QID</a>, <a href='https://seekingalpha.com/symbol/DOG' title='ProShares Short Dow 30 ETF'>DOG</a>, <a href='https://seekingalpha.com/symbol/QLD' title='ProShares Ultra QQQ ETF'>QLD</a>, <a href='https://seekingalpha.com/symbol/DXD' title='ProShares UltraShort Dow30 ETF'>DXD</a>, <a href='https://seekingalpha.com/symbol/UDOW' title='ProShares UltraPro Dow 30 ETF'>UDOW</a>, <a href='https://seekingalpha.com/symbol/SDOW' title='ProShares UltraPro Short Dow 30 ETF'>SDOW</a>, <a href='https://seekingalpha.com/symbol/VFINX' title='Vanguard 500 Index Fund Inv'>VFINX</a>, <a href='https://seekingalpha.com/symbol/EPS' title='WisdomTree Earnings 500 ETF'>EPS</a>, <a href='https://seekingalpha.com/symbol/DDM' title='ProShares Ultra Dow 30 ETF'>DDM</a>, <a href='https://seekingalpha.com/symbol/QQEW' title='First Trust NASDAQ-100 Equal Weight Index ETF'>QQEW</a>, <a href='https://seekingalpha.com/symbol/QQQE' title='Direxion NASDAQ-100 Equal Weighted Index Shares ETF'>QQQE</a>, <a href='https://seekingalpha.com/symbol/SPLX' title='UBS ETRACS Monthly Reset 2xLeveraged S&P 500 total Return ETN'>SPLX</a>, <a href='https://seekingalpha.com/symbol/SFLA' title='iPath Long Extended 3x S&P 500 Index TR Index ETN'>OTC:SFLA</a>, <a href='https://seekingalpha.com/symbol/QQXT' title='First Trust Nasdaq-100 Ex-Tech Sector Index ETF'>QQXT</a>, <a href='https://seekingalpha.com/symbol/SPUU' title='Direxion Daily S&P 500 Bull 2x Shares ETF'>SPUU</a>, <a href='https://seekingalpha.com/symbol/SPXE' title='ProShares S&P 500 Ex-Energy ETF'>SPXE</a>, <a href='https://seekingalpha.com/symbol/UDPIX' title='ProFunds Ultra Dow 30 ProFund Inv'>UDPIX</a>, <a href='https://seekingalpha.com/symbol/OTPIX' title='ProFunds NASDAQ-100 Fund Inv'>OTPIX</a>, <a href='https://seekingalpha.com/symbol/RYARX' title='Rydex Inverse S&P 500® Strategy Fund A'>RYARX</a>, <a href='https://seekingalpha.com/symbol/SPXN' title='ProShares S&P 500 Ex-Financial ETF'>SPXN</a>, <a href='https://seekingalpha.com/symbol/SPDN' title='Direxion Daily S&P 500 Bear 1x Shares ETF'>SPDN</a>, <a href='https://seekingalpha.com/symbol/SPXT' title='ProShares S&P 500 Ex-Technology ETF'>SPXT</a>, <a href='https://seekingalpha.com/symbol/SPXV' title='ProShares S&P 500 Ex-Health Care ETF'>SPXV</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424137\" data-linked=\"Trade war hopes lift global equities\" data-tweet=\"$SPY $QQQ $DIA - Trade war hopes lift global equities https://seekingalpha.com/news/3424137-trade-war-hopes-lift-global-equities?source=tweet\" data-url=\"https://seekingalpha.com/news/3424137-trade-war-hopes-lift-global-equities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}